Upstart Holdings, Inc.
For the period ended Dec 31, 2025. Filed Feb 10, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Feb 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Notes to Consolidated Financial Statements
- Description of Business and Significant Accounting Policies
Description of Business
Upstart Holdings, Inc. and its subsidiaries (together “Upstart”, the “Company”, “management”, “we”, or “our”) apply artificial intelligence (“AI”) models and cloud applications to the process of underwriting consumer credit to more accurately quantify the true risk of a loan. The Company helps originate credit by providing lending partners and auto dealers with access to a proprietary, cloud-based, AI lending marketplace and connects consumers with diverse sources of capital. The Company currently operates in the United States and is headquartered in San Mateo, California. The Company’s fiscal year ends on December 31.
Basis of Presentation and Consolidation
The accompanying consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (“GAAP”) and include the accounts of the Company, its wholly-owned subsidiaries, and consolidated VIEs. All intercompany accounts and transactions have been eliminated. The Company’s functional and reporting currency is the U.S. dollar.
Reclassification
During the fourth quarter of 2025, the Company elected to change its presentation of line of credit receivable (at fair value) on the consolidated balance sheets. The line of credit receivable which was previously presented within other assets was reclassified to be separately presented on the consolidated balance sheets. In addition, the Company elected to combine certain line items within investing activities and financing activities in the consolidated statements of cash flows. Prior year amounts have been reclassified to conform to the current year presentation.
Use of Estimates
The preparation of the consolidated financial statements in conformity with GAAP requires that management make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting periods.
Significant estimates and assumptions made in the accompanying consolidated financial statements, which management believes are critical in understanding and evaluating the Company’s reported financial results include: (i) fair value determinations; (ii) stock-based compensation; (iii) consolidation of VIEs; and (iv) the evaluation for impairment of goodwill. The Company bases its estimates on various factors it believes to be reasonable under the circumstances. Actual results could differ from those estimates and such differences could affect the results of operations reported in future years.
Cash, Cash Equivalents and Restricted Cash
Cash and cash equivalents consists of deposits held with financial institutions in checking and interest-bearing deposit accounts as well as money market accounts. The Company considers all highly liquid investments with original maturities of three months or less to be cash equivalents.
Restricted cash primarily consists of deposit accounts that are held in our custody but restricted for regulatory or legal purposes. Restricted cash includes fiduciary funds received from borrowers for interest and principal applied to loans as part of loan servicing, but not yet distributed to institutional investors as well as collateral provided by institutional investors in relation to loan purchases. Restricted cash also consists of collateral for letters of credit required under operating lease agreements, cash received from borrowers for interest and principal applied to loans pledged to warehouse credit facilities, but not yet distributed to the Company, and cash balances restricted in connection with committed capital and other co-investment arrangements.
Fair Value Measurement
Assets and liabilities recorded at fair value on a recurring basis on the consolidated balance sheets are categorized based upon the level of judgment associated with the inputs used to measure their fair values. Fair value is defined as the exchange price that would be received for an asset or an exit price that would be paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. The price used to measure fair value is not adjusted for transaction costs. The principal market is the market in which the Company would sell or transfer the asset with the greatest volume and level of activity for the asset. In determining the principal market for an asset or liability, it is assumed that the Company has access to the market as of the measurement date. If no market for the asset exists, or if the Company does not have access to the principal market, a hypothetical market is used.
The authoritative guidance on fair value measurements establishes a three-tier fair value hierarchy for disclosure of fair value measurements as follows:
Level 1—Unadjusted quoted market prices in active markets for identical assets or liabilities;
Level 2— Inputs (other than quoted prices included in Level 1) are either directly or indirectly observable for the asset or liability. These include quoted prices for similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active; and
Level 3— Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.
The Company elected to measure the following assets and liabilities under the fair value option: loans, line of credit receivable, notes receivable and residual certificates, servicing rights, beneficial interests (hybrid instruments), and trailing fee liabilities. The Company also measures derivatives at fair value on a recurring basis. When developing fair value measurements, the Company maximizes the use of observable inputs and minimizes the use of unobservable inputs.
However, for certain instruments, the Company must utilize unobservable inputs in determining fair value due to the lack of observable inputs in the market, which requires greater judgment in measuring fair value. In instances where there is limited or no observable market data, fair value measurements for assets and liabilities are based primarily upon the Company’s own estimates, and the measurements reflect information and assumptions that management believes a market participant would use in pricing the asset or liability.
Financial Instruments not Measured at Fair Value
The Company’s financial instruments not measured at fair value consist primarily of cash and cash equivalents, restricted cash, and other assets (excluding certain financial instruments measured at fair value, such as notes receivable and residual certificates, loan servicing assets, and interest rate caps), accounts payable, payable to investors, and other liabilities (excluding certain financial instruments measured at fair value, such as loan servicing liabilities, beneficial interest liabilities, and trailing fee liabilities). Payable to investors includes amounts of loan repayments not yet distributed to institutional investors, as well as amounts received from institutional investors but not yet invested directly in whole loans. The carrying values of these financial instruments approximates their respective fair values due to their short-term nature.
Variable Interest Entities
A legal entity is considered a VIE if it has either a total equity investment that is insufficient to finance its operations without additional subordinated financial support or whose equity holders lack the characteristics of a controlling financial interest. The Company’s variable interests arise from contractual, ownership, or other monetary interests in the entity. The Company consolidates a VIE when it is deemed to be the primary beneficiary. The Company determines it is the primary beneficiary if it has the power to direct activities that most significantly impact the VIE’s economic performance and has the obligation to absorb losses or the right to receive benefits of the VIE that could be potentially significant to the VIE. The Company assesses whether or not it is the primary beneficiary of a VIE on an ongoing basis.
Consolidated Securitization
The Company elected the measurement alternative under Accounting Standards Codification (“ASC”) 810, Consolidation, and maximizes the use of observable inputs to estimate the fair value of the financial assets and liabilities of a consolidated securitization entity. Under the measurement alternative, the Company determined that the fair value of the liabilities, which consists of securitization notes and residual certificates issued by the entity, is based on more observable inputs than inputs used to determine the fair value of the assets, which consists of held-for-sale loans. Thus, the fair value of these loans is determined by the sum of the fair value of the related securitization notes and residual certificates. The fair value is corroborated with discounted cash flow that considers projected prepayments and historical defaults, losses and recoveries to project future losses and net cash flows on loans, discounted using an estimate of market rates of return. The value of residual certificates issued and retained by the Company is eliminated upon consolidation. Changes in the fair value of these assets and liabilities are included in the consolidated statements of operations and comprehensive income (loss).
Loans
Upon origination or purchase, the Company elects the fair value option for all loans. Loans are initially classified as either held-for-investment or held-for-sale based on the Company’s intent and ability to sell such loans prior to maturity, and may subsequently change the classification when our intent or ability changes. Refer to “Note 5. Fair Value Measurement” for further details.
Interest income is recognized based on the terms of the underlying agreements with borrowers and is earned over the life of a loan or a line of credit receivable. Interest income also includes accrued interest earned on outstanding loans and line of credit receivable but not yet collected. Generally, home equity lines of credit (“HELOCs”) that have reached a delinquency over 180 days and all other loans and line of credit receivable that have reached a delinquency over 120 days are charged off and do not accrue interest. The Company does not record an allowance for credit losses on accrued interest receivable. Refer to “Note 2. Revenue” for further details.
Transfer of Financial Assets
Loans sold to third parties are derecognized from the consolidated balance sheets at the time of sale in accordance with ASC 860, Transfers and Servicing. The Company recognizes a gain or loss on the sale as the net assets received from the sale less the carrying amount of loans sold. Assets obtained or liabilities incurred as part of the transaction may include, but are not limited to, cash, servicing rights, beneficial interests, and securities retained from securitizations.
Transfer of financial assets that do not qualify for sale accounting are reported as a secured borrowing. The related assets remain on the Company’s consolidated balance sheets and continue to be reported and accounted for as if the transfer had not occurred. Cash proceeds from these transfers are reported as liabilities, with related interest expense recognized over the life of the related assets.
Loan Servicing Assets and Liabilities
Loan servicing assets and liabilities are recognized at fair value when the Company transfers loans, which qualify as sales under ASC 860 with servicing rights retained or when the Company enters into servicing agreements with lending partners who retain Upstart-powered loans. A loan servicing asset or liability exists depending on whether the revenue from servicing is expected to more than adequately compensate the Company for carrying out its servicing obligations.
Loan servicing assets and liabilities are recorded in other assets and accrued expenses and other liabilities, respectively, in the consolidated balance sheets, with changes in fair value recorded in servicing revenue, net, which is part of revenue from fees, net in the consolidated statements of operations and comprehensive income (loss). Refer to “Note 2. Revenue” for further details.
Property, Equipment, and Software, Net
Property, equipment, and software are stated at cost less accumulated depreciation and amortization. Depreciation and amortization are recognized using the straight-line method over the estimated useful lives of the assets, which are generally three years for internally developed software, computer and networking equipment, and furniture and fixtures. Leasehold improvements are depreciated over the shorter of the remaining lease term or the estimated useful life.
Internally developed software is capitalized upon completion of the preliminary project stage, when it becomes probable that the project will be completed, and the software will be used as intended. Capitalized costs primarily consist of salaries and payroll related costs for employees directly involved in development efforts. Costs related to the preliminary project stage and activities occurring after the implementation of the software are expensed as incurred. Costs incurred for software upgrades are capitalized if they result in additional functionalities or substantial enhancements.
The Company evaluates its long-lived assets for potential impairment when events or changes in circumstances indicate that the carrying amount of the assets may not be recoverable. When such an event occurs the carrying amount of the asset is reduced to its estimated fair value.
Leases
The Company determines if an arrangement is or contains a lease at inception. Operating leases are recorded on the consolidated balance sheets with right-of-use assets representing the right to use the underlying asset and lease liabilities representing the obligation to make lease payments. Right-of-use assets (“ROU”) and lease liabilities are recognized at lease commencement primarily based on the present value of lease payments over the lease term, and as necessary, at modification. The operating lease ROU assets also include any initial direct costs, lease payments made prior to lease commencement, and lease incentives received. Variable lease payments are expensed as incurred and are not included within the ROU asset and lease liability calculation. Variable lease payments primarily include reimbursements of costs incurred by lessors for common area maintenance and utilities. The Company’s lease terms are the non-cancelable period including any rent-free periods provided by the lessor and may include options to extend or terminate the lease when it is reasonably certain that it will exercise that option. At lease inception, and in subsequent periods as necessary, the Company estimates the lease term based on its assessment of extension and termination options that are reasonably certain to be exercised. Lease costs for lease payments are recognized on a straight-line basis over the lease term. As the rate implicit on the Company’s leases is not readily determinable, the Company uses its secured incremental borrowing rate to determine the present value of lease payments. The incremental borrowing rate is the rate of interest that the Company would have to pay to borrow an amount equal to the lease payments on a collateralized basis over a similar term and in a similar economic environment.
The Company has elected not to separate lease and non-lease components for any leases within its existing classes of assets and, as a result, accounts for any lease and non-lease components as a single lease component. The Company has immaterial leases with a term of 12 months or less.
Derivative Financial Instruments
The Company evaluates its contracts and financial instruments to determine if these contracts and instruments or their parts meet the definition of derivatives in accordance with the requirements of ASC 815, Derivatives and Hedging. Derivatives are recorded on the consolidated balance sheets at fair value with changes in the value recorded in earnings on the consolidated statements of operations and comprehensive income (loss), and are reported within the net cash used in operating activities in the consolidated statements of cash flows. The Company uses derivative financial instruments to manage risks related to our ongoing business operations, including managing interest rates on our warehouse facilities. The Company does not employ derivatives for trading or speculative purposes and has no derivatives classified as accounting hedges.
Beneficial Interests
Beneficial interests represent the Company’s right to receive cash payments from or an obligation to make cash payments to certain institutional investors and lending partners based on the credit performance of the underlying loan portfolios. The Company evaluates these arrangements to determine if they or their components meet the characteristics of derivative financial instruments.
In certain arrangements, the Company is obligated to make payments to these third-parties or is entitled to receive payments from them if credit performance of the loans sold or originated under the arrangements deviates from initial expectations set at the time of loan sale or origination. These arrangements meet the definition of derivatives under ASC 815, Derivatives and Hedging, and are measured at their fair value. Under other arrangements, the Company makes an initial investment and is entitled to a portion of cash flows from repayments received over time on the underlying loan portfolios sold under these arrangements. These cash flows vary depending on the demonstrated credit performance relative to our expectations. These arrangements are debt-like financial instruments with embedded derivatives related to the variability of demonstrated credit performance of underlying loan portfolios against initial expectations. The Company elected to account for these hybrid instruments at fair value under ASC 825, Financial Instruments. For all arrangements, changes in fair value and other adjustments are recognized on the consolidated statements of operations and comprehensive income (loss). Refer to “Note 4. Beneficial Interests” and “Note 5. Fair Value Measurement” for additional information.
Non-marketable Equity Securities
The Company’s strategic investments consist of non-marketable equity securities on the consolidated balance sheets which are investments in privately held companies. Non-marketable equity securities do not have a readily determinable fair value and are measured by the Company at cost less impairment, if any, and adjusted for changes resulting from observable price changes in orderly transactions for an identical or similar investment in the same issuer (the “measurement alternative”). Gains and losses on the investment, realized and unrealized, are recognized in other income, net on our consolidated statements of operations and comprehensive income (loss) and a new carrying value is established for the investment upon such recognition of the gains and losses. There have been no unrealized or realized gains and losses or impairments related to the non-marketable equity securities accounted for under the measurement alternative for the years presented.
The determination of whether an orderly transaction is for an identical or similar investment requires significant management judgment. In its evaluation, the Company considers factors such as differences in the rights and preferences of the investment and the extent to which those differences would affect the fair value of the investment. In the event the Company identifies an observable price change from an orderly transaction for an identical or similar investment of the same issuer, the Company must estimate the fair value of its strategic investments using the most recent data available. The Company’s impairment analysis encompasses an assessment of both qualitative and quantitative factors.
Goodwill and Intangible Assets
Goodwill represents the excess of the purchase price over the fair value of identifiable net assets acquired. Goodwill is reviewed for impairment annually, or more frequently if an event or a change in circumstances indicates that goodwill may be impaired. We first assess qualitative factors to determine if it is more likely than not that the fair value of the reporting unit is less than its carrying value. Examples of qualitative factors include, but are not limited to, a significant adverse change in legal factors or in the business climate, a significant decline in our stock price, a significant decline in our projected revenue or cash flows, or the presence of other indicators that would indicate a reduction in the fair value of a reporting unit. If the Company concludes that it is more likely than not that the fair value of the reporting unit is less than its carrying value, a quantitative test is performed. We perform a quantitative goodwill impairment test by determining the fair value of the reporting unit and comparing it to the carrying value of the reporting unit. If the fair value of the reporting unit is greater than the reporting unit’s carrying value, then the carrying value of the reporting unit is deemed to be recoverable. If the carrying value of the reporting unit is greater than the reporting unit’s fair value, goodwill is impaired and written down to the reporting unit’s fair value.
Acquired intangible assets are recorded at fair value on the date of acquisition and amortized on a straight-line basis over their estimated useful lives. Acquired intangible assets are presented net of accumulated amortization on the consolidated balance sheets. The Company reviews the carrying amounts of intangible assets for impairment whenever an event or change in circumstances indicates that the carrying amount of the assets may not be recoverable. We measure the recoverability of intangible assets by comparing the carrying amount of each asset to the future undiscounted cash flows we expect the asset to generate. Impairment is measured by the amount in which the carrying value of the asset exceeds its fair value. In addition, we periodically evaluate the estimated remaining useful lives of long-lived intangible assets to determine whether events or changes in circumstances warrant a revision to the remaining period of amortization.
Borrowings
The Company funds certain aspects of its operations through revolving warehouse credit facilities, risk retention financing facility, and convertible senior notes. Borrowings under revolving warehouse credit facilities are presented at the outstanding balance. Direct costs incurred in connection with these facilities are capitalized as debt issuance costs and presented within other assets on the consolidated balance sheets. These costs are amortized to interest expense on a straight-line basis over the term of the related facilities, which approximates the effective interest method. For non-revolving debt, including risk retention financing facility and convertible senior notes, the difference between the stated principal amount and the cash proceeds received, net of debt issuance costs, is presented as a discount or premium. Debt issuance costs and discount or premiums are amortized into interest expense over the contractual term of the debt using the effective interest method. Interest expense associated with our revolving warehouse credit facilities and risk retention financing facility are presented within “interest expense” on the consolidated statements of operations and comprehensive income (loss). Coupon interest expense and amortization of debt issuance cost associated with our senior convertible notes are presented within “expense on convertible notes” on the consolidated statements of operations and comprehensive income (loss). Accrued interest on borrowings is presented within accrued expenses and other liabilities on the consolidated balance sheets. The carrying value of borrowings associated with the warehouse credit facilities approximates the fair value due to their relatively short maturities.
Revenue Recognition
The Company’s revenue consists oftwo components: revenue from fees, net and interest income, interest expense, and fair value adjustments, net. The revenue from fees, net line item on the consolidated statements of operations and comprehensive income (loss) is primarily comprised of platform and referral fees, net which are recognized in accordance with ASC 606, Revenue from Contracts with Customers, origination fees which are accounted for under ASC 310, Receivables, and servicing and other fees, net, which are accounted for under ASC 860, Transfers and Servicing. Refer to “Note 2. Revenue” for further information.
Operating Expenses
Sales and marketing expenses primarily consist of costs incurred across various advertising channels, including expenses for partnerships with third-parties providing borrower referrals, direct mail and digital advertising campaigns, as well as other expenses associated with building overall brand awareness and experiential marketing costs. Sales and marketing expenses also include payroll and other personnel-related costs, including stock-based compensation expense, for related teams. These costs are recognized in the period incurred.
Customer operations expenses include payroll and other personnel-related expenses, including stock-based compensation expense, for personnel engaged in onboarding, loan servicing, customer support and other related operational teams. These costs also include costs of third-party collection agencies and other systems and tools the Company uses as part of information verification, fraud detection, and payment processing activities. These costs are recognized in the period incurred.
Engineering and product development expenses primarily consist of payroll and other employee-related expenses, including stock-based compensation expenses, for the engineering and product development teams as well as the costs of systems and tools used by these teams. These costs are recognized in the period incurred.
General, Administrative, and Other
General, administrative, and other expenses consist primarily of payroll and other employee-related expenses, including stock-based compensation expense for legal and compliance, finance and accounting, human resources and facilities teams, as well as depreciation and amortization of property, equipment and software, professional services fees, facilities and travel expenses. These costs are recognized in the period incurred.
Stock-Based Compensation
The Company issues stock options and restricted stock units (“RSUs”) to employees and non-employees, including directors, and employee stock purchase rights granted under the Company’s employee stock purchase plan (“ESPP”). The Company also had previously granted performance-based restricted stock units (“PRSUs”). Stock options and employee stock purchase rights granted under the ESPP are initially measured at fair value at the date of grant using the Black-Scholes option-pricing model. RSUs and restricted stock are measured at the fair market value of our common stock at the grant date. PRSUs are initially measured at fair value using a Monte Carlo simulation model.
Stock-based compensation expenses are recognized based on their respective grant-date fair values and recognized over the requisite service period. Forfeitures are estimated at the time of grant and revised, as necessary, in subsequent periods if actual forfeitures differ from initial estimates. Stock-based compensation expense is recorded net of estimated forfeitures, such that the expense is recorded only for those awards that are expected to vest.
Other income, net primarily consists of dividend income earned by the Company on its cash, cash equivalents and restricted cash balances which is recognized in the period earned.
Income Taxes
Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the consolidated financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled.
The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. A valuation allowance may be established to reduce the deferred tax asset to the level at which it is “more likely than not” that the tax asset or benefits will be realized. Realization of tax benefits of deductible temporary differences and operating loss carryforwards depends on having sufficient taxable income of an appropriate character within the carryback or carryforward periods.
The Company recognizes the effect of income tax positions only if those positions are more likely than not of being sustained upon review by the taxing authority. Recognized income tax positions are measured at the largest amount that is greater than 50% likely of being realized. Changes in recognition or measurement are reflected in the period in which the change in judgment occurs.
Net Income (Loss) Per Share
Basic net income (loss) per share is computed by dividing the net income (loss) attributable to common stockholders by the weighted-average number of common shares outstanding for the year.
Diluted net income (loss) per share is the amount of net income (loss) available to each share of common stock outstanding during the reporting year, adjusted to include the effect of potentially dilutive common shares. Potentially dilutive common shares include incremental shares issued for stock options, unvested RSUs, purchase rights committed under the ESPP, and convertible debt. The calculation of diluted net income (loss) per share excludes all anti-dilutive common shares. For years in which the Company reports net losses, basic and diluted net loss per share are the same because potentially dilutive common shares are not assumed to have been issued if their effect is anti-dilutive.
Recently Adopted Accounting Pronouncements
In December 2023, the Financial Accounting Standards Board (“FASB”) issued Accounting Standard Update (“ASU”) 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures. The amendments in this update require entities to disclose specific categories in the effective tax rate reconciliation and provide additional information for reconciling items where the effect of those reconciling items is equal to or greater than 5% of the amount computed by multiplying pretax income/loss by the applicable statutory income tax rate. In addition, entities are required to disclose the year-to-date amount of income taxes paid (net of refunds received)
disaggregated by jurisdictions. The Company adopted this standard effective for its 2025 Annual Report on Form 10-K and has made the required disclosures. Refer to “Note 12. Income Taxes” for disclosures.
Recently Issued Accounting Pronouncements
In November 2024, the FASB issued ASU 2024-03 and subsequently ASU 2025-01, Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses. The amendments in this update require disaggregated disclosures in the notes to the financial statements for certain expenses such as employee compensation, depreciation, and intangible asset amortization, which are commonly presented in aggregate. This ASU is effective for annual periods beginning after December 15, 2026 and interim periods beginning after December 15, 2027 with early adoption permitted. The Company is currently evaluating the impact of these amendments to its consolidated financial statements and related disclosures.
In November 2024, the FASB issued ASU 2024-04, Debt—Debt with Conversion and Other Options (Subtopic 470-20): Induced Conversions of Convertible Debt Instruments. The amendments in this update clarify the requirements for determining whether certain settlements of convertible debt instruments should be accounted for as an induced conversion. This ASU is effective for annual reporting periods beginning after December 15, 2025 with early adoption permitted. The Company will adopt the ASU prospectively and as such, does not expect an impact to its consolidated financial statements upon adoption.
In September 2025, the FASB issued ASU 2025-06, Intangibles—Goodwill and Other—Internal-Use Software (Subtopic 350-40): Targeted Improvements to the Accounting for Internal-Use Software. The amendments in this update remove references to software development project stages and introduce a “probable-to-complete” threshold to determine when software development costs should be capitalized. This ASU is effective for annual reporting periods beginning after December 15, 2027 with early adoption permitted. The Company is currently evaluating the impact of these amendments to its consolidated financial statements.
In December 2025, the FASB issued ASU 2025-11, Interim Reporting (Topic 270): Narrow-Scope Improvements. The amendments in this update clarify the existing interim requirements including introducing a disclosure principle that entities should disclose material events since the end of the last annual reporting period. The amendments do not expand or reduce the current interim disclosure requirements. This ASU is effective for interim periods within annual reporting periods beginning after December 15, 2027 with early adoption permitted. The Company is currently evaluating the impact of these amendments on its consolidated financial statements and related disclosures.
- Revenue
The Company disaggregates revenue from fees by type of service for the years presented as follows:
| Year Ended December 31, | |||
|---|---|---|---|
| 2023 | 2024 | 2025 | |
| Revenue from fees, net: | |||
| Platform and referral fees, net | $414,120 | $502,411 | $792,979 |
| Servicing and other fees, net | 146,311 | 133,055 | 157,032 |
| Total revenue from fees, net | $560,431 | $635,466 | $950,011 |
Platform and Referral Fees, Net
Platform and referral fees, net consists of (i) platform and referral fees received from lending partners, (ii) subscription fees received from auto dealerships, and (iii) origination fees received from borrowers, as described below.
Platform and referral fees. The Company enters into contracts with its lending partner customers, to provide access to a cloud-based AI lending marketplace developed by the Company (the “Upstart platform”) to enable lending partners to originate unsecured personal and secured auto refinance loans. The Upstart platform includes a cloud-based application (through Upstart.com) for submitting loan applications, verifying information provided within submitted applications, risk underwriting (through a series of proprietary technology solutions), delivery of electronic loan offers, and if the offer is accepted by the borrower, electronic loan documentation signed by the borrower. Lending partners can specify certain parameters of loans they are willing to originate. Under these contracts, lending partners can choose to use Upstart’s referral services, which allow them to access new borrowers through Upstart’s marketing channels.
After origination, Upstart-powered loans are either retained by lending partners, purchased by the Company for immediate resale to institutional investors under loan sale agreements, or purchased and held by the Company. For loans not retained by the lending partners, the Company pays the lending partners a one-time loan premium fee upon completion of the minimum contractual holding period and a monthly loan trailing fee based on the amount and timing of principal and interest payments made by the borrowers of the underlying loans. Both the loan premium fees and loan trailing fees are consideration payable to customers, which are our lending partners, and are recorded as a reduction to platform and referral fees, net, which is part of revenue from fees, net, in the consolidated statements of operations and comprehensive income (loss). The Company recognized $8.1 million, $11.5 million, and $18.2 million of loan premium fees and loan trailing fees as contra-revenue within platform and referral fees, net during the years ended December 31, 2023, 2024 and 2025, respectively.
As of December 31, 2024 and 2025, the Company recognized $4.6 million and animmaterial amount of loan trailing fee liability, respectively, which is recorded at fair value and included within accrued expenses and other liabilities on the Company’s consolidated balance sheets. Refer to “Note 5. Fair Value Measurement” for additional information on changes in fair value associated with trailing fee liabilities.
The Company’s arrangements for platform and referral services typically consist of an obligation to provide one or both of these services to customers, on a when and if needed basis (a stand-ready obligation), and revenue is recognized as such services are performed. Additionally, the services have the same pattern and period of transfer, and when provided individually or together, are accounted for as a single combined performance obligation representing a series of distinct services.
Platform and referral services are typically provided under a fixed or variable price per unit based on a percentage of the value of loans originated each period with certain lending partners subject to minimum fees; however, pricing for these services may also be based on usage fees, calculated as a percentage of each loan originated. The nature of the Company’s promise is to stand-ready and provide continuous access to and process transactions through the platform. Platform and referral fees represent variable consideration as loan origination volume is not known at contract inception. These fees are determined each time a loan is originated. Fees for platform and referral services are generally billed and paid on a monthly basis, or settled on a daily basis. As such, the Company’s contracts with customers do not include a significant financing component.
Subscription fees. The Company enters into subscription agreements with auto dealerships to access Upstart Auto Finance software, a cloud-based solution that facilitates dealership operations and enables them to provide consumers with access to Upstart-powered auto loans. Subscription agreements generally have a contractual term ofone tosix months with evergreen monthly renewals. The Company bills these customers on a monthly basis. Subscription fees are recognized over the contract term as the performance obligation is satisfied, and is included within platform and referral fees, net in the consolidated statements of operations and comprehensive income (loss). The Company recognized $3.8 million, $5.4 million, and $4.7 million of subscription fee revenue for the years ended December 31, 2023, 2024 and 2025, respectively.
Origination fees. Origination fees are earned from borrowers on HELOCs originated by the Company. Origination fees werenot material for the years ended December 31, 2023 and 2024, and were $7.6 million for the year ended December 31, 2025.
The Company had $19.0 million and $25.8 million of accounts receivable, excluding those that are settled on a daily basis, that are included in other assets on the consolidated balance sheets related to contracts with customers as of December 31, 2024 and 2025, respectively. The standard payment terms on accounts receivable are 30 days. The Company’s allowance for bad debt and bad debt expense were immaterial for the periods presented.
The Company capitalizes incremental costs of obtaining a contract with a customer, which are certain sales commissions paid to employees in connection with the acquisition of lending partners. Capitalized costs are amortized over the expected period of benefit, which we have determined, based on an analysis, to bethree years. The Company applies the practical expedient to expense costs to obtain contracts with customers if the amortization period is one year or less. As of December 31, 2024 and 2025, the Company had $2.5 million and animmaterial amount, respectively, of contract costs capitalized within other assets on the consolidated balance sheets. During the years ended December 31, 2023, 2024 and 2025, the Company recognized an amortization expense of $3.2 million, $3.2 million, and animmaterial amount, respectively, of capitalized contracts costs to sales and marketing in the consolidated statements of operations and comprehensive income (loss) for the years presented.
Customers accounting for greater than 10% of total revenue were as follows:
| Year Ended December 31, | |||
|---|---|---|---|
| 2023 | 2024 | 2025 | |
| Customer A | * | 10% | 33% |
| Customer B | 29% | 26% | 20% |
| Customer C | 23% | 27% | * |
| Customer D | 11% | * | * |
- Less than 10%
Customers accounting for greater than 10% of accounts receivable were as follows:
| December 31, 2024 | December 31, 2025 | |
|---|---|---|
| Customer D | * | 16% |
| Customer E | 15% | 16% |
- Less than 10%
Servicing and Other Fees, Net
The Company also enters into contracts with lending partners and institutional investors, including securitization trusts and pass-through entities to provide loan servicing for the life of Upstart-powered loans. These services commence upon origination of these loans by lending partners and include collection, processing and reconciliations of payments received, institutional investor reporting and borrower customer support as well as distribution of funds to the holders of the loans. The Company charges the loan holder a monthly servicing fee calculated based on a predetermined percentage of the outstanding principal balance. Servicing fees also include certain ancillary fees charged on a per transaction basis for processing late payments and payments declined due to insufficient funds. Servicing fees are recognized in the period the services are provided.
The Company charges lending partners and institutional investors for collection agency fees related to their outstanding loan portfolio. The Company either performs borrower collection activities in-house, or outsources to third-party collection agencies, including for loans that are charged off. The Company has discretion in hiring the collection agencies and determining the scope of their work. As the principal in the arrangement, the Company recognizes gross revenue from collection agency fees in the period that the services are provided. Upstart also receives certain ancillary borrower fees inclusive of late payment fees and ACH fail fees. The total fees charged by collection agencies are recognized in the period incurred and reported as part of customer operations expenses.
Servicing and other fees, net also includes gains and losses on assets and liabilities recognized under loan servicing arrangements for loans retained by lending partners or loans sold to institutional investors. Such gains or losses are recognized based on whether the benefits of servicing are expected to be more or less than adequate compensation for servicing obligations performed by the Company. Servicing fees also include changes in fair value of loan servicing assets and liabilities. Refer to “Note 5. Fair Value Measurement” for additional information on changes in fair value associated with servicing assets and liabilities.
The following table presents the components of servicing and other fees, net as part of revenue from fees, net in the Company’s consolidated statements of operations and comprehensive income (loss):
| Year Ended December 31, | |||
|---|---|---|---|
| 2023 | 2024 | 2025 | |
| Servicing fees | $107,008 | $89,323 | $100,164 |
| Borrower fees | 29,139 | 26,444 | 29,375 |
| Collection agency fees | 15,865 | 16,405 | 14,434 |
| Other fees | 743 | 677 | 2,760 |
| Net gain (loss) on servicing rights and fair value adjustments | (6,444) | 206 | 10,299 |
| Total servicing and other fees, net | $146,311 | $133,055 | $157,032 |
Interest income, interest expense, and fair value adjustments, net is comprised of interest income, interest expense and net changes in the fair value of financial instruments held in the Company’s normal course of business at fair value, including loans, derivatives, beneficial interests, notes receivable and residual certificates, trailing fee liabilities, payable to securitization note holders, and line of credit receivable.
The following table presents components of the interest income, interest expense, and fair value adjustments, net presented in the Company’s consolidated statements of operations and comprehensive income (loss):
| Year Ended December 31, | |||
|---|---|---|---|
| 2023 | 2024 | 2025 | |
| Interest income(1) | $168,996 | $186,360 | $204,230 |
| Interest expense(1) | (34,894) | (40,433) | (31,664) |
| Fair value and other adjustments, net: | |||
| Unrealized loss on loans, loan charge-offs, and other fair value adjustments, net(1) | (130,440) | (111,175) | (83,088) |
| Realized loss on sale of loans, net | (24,042) | (15,983) | (12,237) |
| Fair value adjustments and realized gains (losses) on beneficial interests, net | (26,489) | (17,707) | 16,605 |
| Total fair value and other adjustments, net | (180,971) | (144,865) | (78,720) |
| Total interest income, interest expense, and fair value adjustments, net | $(46,869) | $1,062 | $93,846 |
(1) Includes interest income, interest expense and unrealized loss on loans, loan charge-offs, and other fair value adjustments, net related to the consolidated securitization as follows:
| Year Ended December 31, | |||
|---|---|---|---|
| 2023 | 2024 | 2025 | |
| Interest income, interest expense, and fair value adjustments, net related to consolidated securitization: | |||
| Interest income | $19,697 | $28,968 | $16,593 |
| Interest expense | (6,733) | (9,598) | (6,313) |
| Unrealized loss on loans, loan charge-offs, and other fair value adjustments, net | (5,496) | (29,396) | (11,114) |
| Total interest income, interest expense, and fair value adjustments, net | $7,468 | $(10,026) | $(834) |
Interest Income
As of December 31, 2024 and 2025, the Company has recorded $8.2 million and $10.2 million, respectively of accrued interest income inloans on the consolidated balance sheets. Accrued interest income on the line of credit receivable was immaterial as of both December 31, 2024 and 2025.
Interest Expense
Interest expense is primarily related to interest recorded on the Company’s borrowings on warehouse credit facilities and interest expense related to the consolidated securitization. Interest expense includes accrued interest incurred but not paid. Interest expense also includes changes in fair value of the interest rate caps. Accrued interest expenses for the warehouses were immaterial as of December 31, 2024 and 2025.
Fair Value and Other Adjustments, Net
Fair value and other adjustments, net include changes in fair value of financial instruments, other than loan servicing assets and liabilities and interest rate caps. These adjustments are recorded in the Company’s consolidated statements of operations and comprehensive income (loss) and include both realized and unrealized changes to the value of related assets and liabilities. Refer to “Note 5. Fair Value Measurement” for additional information.
Fair value and other adjustments, net also includes amounts received from borrowers for previously charged-off loans held on the Company’s consolidated balance sheets. These amounts are recognized in the period when amounts are received. Amounts received from borrowers for previously charged-off loans were $7.2 million, $14.6 million, and $17.6 million for the years ended December 31, 2023, 2024 and 2025, respectively.
- Variable Interest Entities
Consolidated VIEs
The Company consolidates VIEs in which the Company has a variable interest and is determined to be the primary beneficiary. This determination is based on whether the Company has a variable interest (or combination of variable interests) that provides the Company with both (a) the power to direct the activities that most significantly impact the VIE’s economic performance and (b) the obligation to absorb losses or right to receive benefits that could be potentially significant to the VIE. The Company continually reassesses whether it is the primary beneficiary of a VIE throughout the entire period the Company is involved with the VIE.
The Company also determines whether decision-maker or service-provider fees are variable interests. Decision-maker or service-provider fees are not considered variable interests when the arrangement does not expose the Company to risks of loss that a potential VIE was designed to pass on to its variable interest holders, the fees are commensurate, the arrangement is at market, and the Company does not have any other interests (including direct interests and certain indirect interests held through related parties) that absorb more than an insignificant amount of a VIE’s potential variability. This determination can have a significant impact on the Company’s consolidation analysis, as it could affect whether a legal entity is a VIE and whether the Company is the primary beneficiary of a VIE. When the Company’s decision-maker or service-provider fee is not a variable interest, the Company is viewed as acting as a fiduciary for the potential VIE.
The following tables present a summary of financial assets and liabilities from the Company’s involvement with consolidated VIEs:
| Assets | Liabilities | Net Assets | |
|---|---|---|---|
| Consolidated securitization | $109,739 | $87,322 | $22,417 |
| Consolidated warehouse entities | 430,887 | 196,982 | 233,905 |
| Other consolidated VIEs | 271,483 | 3,270 | 268,213 |
| Total consolidated VIEs | $812,109 | $287,574 | $524,535 |
| Assets | Liabilities | Net Assets | |
|---|---|---|---|
| Consolidated securitization | $58,275 | $46,542 | $11,733 |
| Consolidated warehouse entities | 167,158 | 101,791 | 65,367 |
| Other consolidated VIEs | 690,522 | 19,111 | 671,411 |
| Total consolidated VIEs | $915,955 | $167,444 | $748,511 |
Consolidated Securitization
On July 6, 2023, the Company completed a private securitization securities offering (“UPST 2023-2”). As a retaining sponsor of the transaction, under risk retention requirements in Title 17 U.S. Code of Federal Regulations Part 246, Credit Risk Retention, promulgated by the SEC, the Company is required to retain at least 5% of the economic risk in UPST 2023-2. The Company elected to satisfy the risk retention requirements by holding eligible vertical retained interests in the form of a combination of securitization notes and residual certificates. The Company has also retained the remainder of the residual certificates issued as part of the transaction. The Company was the sole contributor of the collateral, which included $204.7 million outstanding principal balance of Upstart-powered loans held by the Company. The weighted-average coupon of the securitization notes issued was approximately 9.2%, and their sale generated approximately $165.3 million in gross cash proceeds. These proceeds and payments made on securitization notes are classified as financing activities in the consolidated statement of cash flows.
The retained interests in UPST 2023-2 held by the Company were deemed to potentially absorb more than an insignificant amount of expected losses or expected returns at the inception of the securitization transaction. The Company, as servicer, also has the power to direct the activities that most significantly impact the economics of the entities associated with the UPST 2023-2 securitization, and as such, the Company determined it was the primary beneficiary and consolidated the entities associated with UPST 2023-2.
The loans held in the consolidated securitization trust are classified as held-for-sale and included in loans, at fair value, and the notes sold to third-party investors are recorded at fair value as payable to securitization note holders on the consolidated balance sheets. Refer to “Note 5. Fair Value Measurement” for additional information on determination of fair value of these assets and liabilities. The value of the residual certificates issued as part of the securitization and retained by the Company was eliminated as part of the consolidation.
Warehouse Entities
The Company established various entities deemed to be VIEs to enter into warehouse credit facilities for the purpose of purchasing Upstart-powered loans. Refer to “Note 8. Borrowings” for additional information. These entities are Delaware statutory trusts that are structured to be bankruptcy-remote, with third-party banks operating as trustees.
Other Consolidated VIE
The Company has formed a number of VIEs for the purpose of holding Upstart-powered loans that are not pledged or eligible to be pledged to the Company’s warehouse credit facilities. In addition, the Company has formed consolidated VIEs for the purpose of holding restricted cash or loans as collateral in connection with committed capital and other co-investment arrangements.
Unconsolidated VIEs
The Company’s transactions with unconsolidated VIEs include securitizations of unsecured personal whole loans and sales of whole loans to VIEs, including loan sales under its committed capital and other co-investment arrangements. Refer to “Note 4. Beneficial Interests” for additional information on unconsolidated VIEs related to committed capital and other co-investment arrangements.
Securitizations
While the Company continues to be involved with the unconsolidated VIEs in its role as the sponsor and the servicer of securitization transactions, the Company has determined that it is not the primary beneficiary of these entities. The Company’s unconsolidated VIEs include entities established as the issuers and grantor trusts for various securitization transactions.
In cases where the VIEs are not consolidated and the transfer of the loans from the Company to the securitization trust meets sale accounting criteria, the Company recognizes a gain or loss on sales of loans. The net proceeds of the sale represent the fair value of any assets obtained or liabilities incurred as part of the transaction. The assets are transferred into a trust such that the assets are legally isolated from the creditors of the Company and are not available to satisfy obligations of the Company. These assets can only be used to settle obligations of the underlying securitization trusts.
During the year ended December 31, 2024, the Company exercised clean up calls related totwo unconsolidated securitizations and subsequently liquidated the associated entities. As part of the clean up calls, the Company, as servicer, repurchased the remaining collateral and received the cash reserve amounts held by the related entities. The clean up calls had no material impact on the consolidated financial statements of the Company for the years presented.
The following tables summarize the aggregate value of assets and liabilities of unconsolidated VIEs associated with securitizations in which the Company holds a variable interest but is not the primary beneficiary:
| Assets(1) | Liabilities | Net Assets | Maximum Exposure to Losses | |
|---|---|---|---|---|
| Securitizations | $507,666 | $363,890 | $143,776 | $25,774 |
(1) Represents cash and the unpaid principal balance of loans held by the unconsolidated VIEs.
| Assets(1) | Liabilities | Net Assets | Maximum Exposure to Losses | |
|---|---|---|---|---|
| Securitizations | $2,016,813 | $1,426,987 | $589,826 | $101,670 |
(1) Represents cash and the unpaid principal balance of loans held by the unconsolidated VIEs.
The Company’s maximum exposure to loss from its involvement with unconsolidated VIEs represents the value of securities retained and cash deposits made under the risk retention requirements for the related securitizations and estimates the loss that would be incurred under severe, hypothetical circumstances, for which the Company believes the possibility is remote. The carrying value of assets that relate to variable interests in unconsolidated VIEs consists of $22.1 million and $97.4 million of securitization notes and residual certificates that are carried at fair value and included in other assets on the consolidated balance sheets as of December 31, 2024 and 2025, respectively. The Company also had $3.7 million and animmaterial amount of cash deposits held as reserve accounts for related securitizations, included in other assets on the consolidated balance sheets as of December 31, 2024 and 2025, respectively.
For securitization transactions where the Company is not the risk retaining sponsor, and servicing is the only form of continuing involvement, the Company would only experience a loss if it were required to repurchase a loan due to a breach in representations and warranties and is not able to collect all repayments, refer to “Note 11. Commitments and Contingencies” for further information.
The investors and the securitization trusts have no direct recourse to the Company’s assets, and holders of the securities issued by the securitization trusts can look only to the assets of the securitization trusts that issued their securities for payment. The interests held by the Company and its affiliates are subject principally to the credit and prepayment risk stemming from the underlying unsecured personal whole loans.
- Beneficial Interests
The Company’s beneficial interests are associated with committed capital and other co-investment arrangements with a number of third-party institutional investors and lending partners, in which the Company puts certain amounts of assets at risk. The risk is subject to a dollar cap, which represents the Company’s maximum exposure to losses in each particular arrangement.
In certain arrangements, the Company is obligated to make payments to these third-parties or is entitled to receive payments from them if credit performance of the loans sold or originated under the arrangements deviates from initial expectations set at the time of loan sale or origination. These arrangements meet the definition of derivatives under ASC 815 and produce an asset or a liability depending on the credit performance of the underlying loan portfolio as of the reporting date, which are settled periodically in cash based on contractual terms. Under other arrangements, the Company makes an initial investment and is entitled to a portion of cash flows from repayments received over time on the underlying loan portfolios sold under these arrangements. These cash flows vary depending on the demonstrated credit performance relative to our expectations. These arrangements are debt-like financial instruments with embedded derivatives related to the variability of demonstrated credit performance of underlying loan portfolios against initial expectations. The Company accounts for these derivatives and hybrid instruments at fair value under ASC 815 and ASC 825, respectively. Refer to “Note 5. Fair Value Measurement” for additional information.
Beneficial interests represent the value of the future cash flows based on expected performance, discounted to the present value. The following table presents the aggregate outstanding principal balance of the underlying loan portfolios as well as the fair value of beneficial interest assets, by type, which collectively are presented as a separate caption on the consolidated balance sheets, and beneficial interest liabilities, which are presented in accrued expenses and other liabilities on the consolidated balance sheets.
| December 31, 2024 | December 31, 2025 | |||
|---|---|---|---|---|
| Outstanding Principal Balance | Fair Value | Outstanding Principal Balance | Fair Value | |
| Beneficial interest assets (hybrid instruments) | $2,214,535 | $168,091 | $4,530,737 | $372,402 |
| Beneficial interest assets (derivatives) | 1,943,215 | 8,757 | 2,559,210 | 23,814 |
| Total beneficial interest assets | $4,157,750 | $176,848 | $7,089,947 | $396,216 |
| Beneficial interest liabilities (derivatives) | $1,091,538 | $10,089 | $2,325,305 | $5,075 |
The Company recognizes beneficial interests at fair value with changes reported as part of the fair value and other adjustments on the consolidated statements of operations and comprehensive income (loss). The table below presents net gains and losses recognized on beneficial interests during the following years:
| Year Ended December 31, | |||
|---|---|---|---|
| 2023 | 2024 | 2025 | |
| Fair value adjustments and realized gains (losses) on beneficial interests, net | $(26,489) | $(17,707) | $16,605 |
The Company’s beneficial interests are associated with entities that meet the definition of a VIE or are evaluated under the voting interest model. The Company has variable interests in certain entities established in relation to its committed capital and co-investment arrangements, including purchaser trusts, which are unconsolidated VIEs. While the Company holds variable interests in these unconsolidated VIEs through committed capital and co-investment arrangements and as the servicer of the loans sold, the Company does not have the power to direct the activities that most significantly impact the VIE’s economic performance and has determined that it is not the primary beneficiary of these entities. The Company additionally holds loans as collateral in connection with committed capital and other co-investment arrangements in a consolidated VIE. Refer to “Note 3. Variable Interest Entities” for additional information. While held as collateral, these loans are ineligible to be sold and are classified as held-for-investment on the Company’s consolidated balance sheets.
The contractual terms of committed capital and other co-investment arrangements also determine the Company’s maximum exposure to losses and dictate types of assets the Company puts at risk. The Company’s maximum exposure to losses from its involvement with these arrangements are estimated under severe, hypothetical circumstances, for which the Company believes the possibility is remote. The following table presents the Company’s aggregate maximum exposure to losses by asset type:
| December 31, 2024 | December 31, 2025 | |
|---|---|---|
| Cash and cash equivalents | $85,105 | $160,055 |
| Restricted cash | 84,065 | 219,412 |
| Beneficial interests | 204,814 | 389,566 |
| Line of credit receivable(1) | 54,780 | 108,965 |
| Loans(1) | 30,579 | 53,762 |
| Total(2) | $459,343 | $931,760 |
(1) Represents the unpaid principal balance.
(2) $137.4 million and $191.6 million as of December 31, 2024 and 2025, respectively, is related to assets held by one institutional investor.
- Fair Value Measurement
The following table presents assets and liabilities measured at fair value and categorized in accordance with the fair value hierarchy:
| Level | December 31, 2024 | December 31, 2025 | |
|---|---|---|---|
| Assets | |||
| Loans | 3 | $806,304 | $984,552 |
| Beneficial interest assets | 3 | 176,848 | 396,216 |
| Line of credit receivable | 3 | 56,269 | 112,742 |
| Loan servicing assets | 3 | 27,439 | 40,941 |
| Notes receivable and residual certificates | 3 | 22,055 | 97,416 |
| Interest rate cap(1) | 2 | 1,864 | 225 |
| Total assets | $1,090,779 | $1,632,092 | |
| Liabilities | |||
| Payable to securitization note holders | 3 | $87,321 | $46,542 |
| Beneficial interest liabilities | 3 | 10,089 | 5,075 |
| Trailing fee liabilities | 3 | 4,614 | 5,761 |
| Loan servicing liabilities | 3 | 1,180 | 4,383 |
| Total liabilities | $103,204 | $61,761 | |
(1) The fair value of the interest rate cap is determined based on the present value of the estimated future cash flows over the contract term using observable market-based inputs as of the valuation date, including implied interest rates.
Financial instruments are categorized in the fair value hierarchy based on the significance of unobservable inputs and assumptions in the overall fair value measurement. Financial instruments classified as Level 3 within the fair value hierarchydo not trade in an active market with readily observable prices. The Company uses significant unobservable inputs to measure the fair value of these assets and liabilities. There were no transfers between Level 1, Level 2 or Level 3 of the fair value hierarchy during the years presented.
Loans
Loans included in the Company’s consolidated balance sheets are classified as either held-for-sale or held-for-investment based on the Company’s intent and ability to sell the loans prior to maturity. From time to time, the Company transfers loans between the classification categories based on changes in the Company’s intent and ability. Loans held in the consolidated securitization include loans contributed as collateral to and held in the consolidated securitization (UPST 2023-2) and are classified as held-for-sale.
The following table presents the fair value of classes of loans included in the Company’s consolidated balance sheets as of December 31, 2024 and 2025:
| December 31, 2024 | December 31, 2025 | |
|---|---|---|
| Loans held-for-sale | $405,812 | $393,159 |
| Loans held-for-investment | 297,543 | 537,631 |
| Loans held in consolidated securitization | 102,949 | 53,762 |
| Total | $806,304 | $984,552 |
Loans held-for-sale and held-for-investment are measured at estimated fair value using a discounted cash flow model. The fair valuation methodology considers projected prepayments and historical defaults, losses and recoveries to project future losses and net cash flows on loans. Net cash flows are discounted using an estimate of market rates of return. The fair value of these loans also includes accrued interest.
The Company elected the measurement alternative under Topic 810, Consolidation, and maximizes the use of observable inputs to estimate the fair value of the financial assets and liabilities of UPST 2023-2. Under the measurement alternative, the Company determined that inputs and market data used to determine the value of UPST 2023-2 liabilities, which consist of securitization notes and residual certificates issued as part of this securitization, are more observable than those used to measure fair value of UPST 2023-2 financial assets, which consist of held-for-sale loans contributed as collateral. Thus, the loans are measured based on the sum of the fair value of the UPST 2023-2 securitization notes and residual certificates, with changes in fair value included in the consolidated statements of operations and comprehensive income (loss). The fair value is also corroborated with discounted cash flow that considers projected prepayments and historical defaults, losses and recoveries to project future losses and net cash flows on loans, discounted using an estimate of market rates of return as disclosed below in the “Significant Inputs and Assumptions” section. The fair value of loans in consolidated securitization also includes accrued interest.
The following table presents quantitative information about the significant unobservable inputs used for the Company’s Level 3 fair value measurements for loans held-for-investment and held-for-sale, excluding loans held in consolidated securitization:
| December 31, 2024 | December 31, 2025 | |||||
|---|---|---|---|---|---|---|
| Minimum | Maximum | Weighted-Average (1) | Minimum | Maximum | Weighted-Average (1) | |
| Discount rate | 9.75% | 22.37% | 11.91% | 5.00% | 14.78% | 9.51% |
| Credit risk rate | 0.01% | 93.12% | 17.87% | 0.01% | 91.50% | 15.52% |
| Prepayment rate | 0.45% | 89.07% | 33.07% | 0.45% | 99.75% | 43.41% |
The following table presents quantitative information about the significant unobservable inputs implied for the Company’s Level 3 fair value measurements for loans held in consolidated securitization, which is determined by the sum of the fair value of the related securitization notes and residual certificates, and corroborated with a discounted cash flow model, similar to the one used for other loans held on the consolidated balance sheet:
| December 31, 2024 | December 31, 2025 | |||||
|---|---|---|---|---|---|---|
| Minimum | Maximum | Weighted-Average (1) | Minimum | Maximum | Weighted-Average (1) | |
| Discount rate | 5.96% | 15.25% | 9.59% | 6.99% | 15.00% | 10.43% |
| Credit risk rate | 0.67% | 37.70% | 15.66% | 0.67% | 35.68% | 16.12% |
| Prepayment rate | 6.73% | 89.84% | 41.51% | 6.73% | 89.84% | 40.50% |
Discount rates–The discount rates are rates of return used to discount future expected cash flows to arrive at a present value, which represents the fair value. The discount rates used for the projected net cash flows are the Company’s estimates of the rates of return that market participants would require when investing in these financial instruments with cash flows dependent on credit quality of the related loan. A risk premium component is implicitly included in the discount rates to reflect the amount of compensation market participants require due to the uncertainty inherent in the instruments’ cash flows resulting from risks such as credit and liquidity.
Credit risk rates–The credit risk rates are an estimate of the net cumulative principal payments that will not be repaid over the entire life of a financial instrument. The credit risk rates are expressed as a percentage of the original principal amount of the instrument. The estimated net cumulative loss represents the sum of the net losses estimated to occur each month of the life of the instrument, net of the average recovery expected to be received.
Prepayment rates–Prepayment rates are an estimate of the cumulative principal prepayments that will occur over the entire life of a loan as a percentage of the original principal amount of the loan. The assumption regarding cumulative prepayments impacts the projected balances and expected terms of the loans.
The following table presents the sensitivity of the fair value of loans held-for-sale and held-for-investment, excluding the loans in consolidated securitization, to adverse changes in key assumptions used in the valuation model as of December 31, 2024 and 2025:
| December 31, 2024 | December 31, 2025 | |
|---|---|---|
| Fair value of loans held-for-sale and held-for-investment | $703,355 | $930,790 |
| Discount rates | ||
| 100 basis point increase | (9,048) | (12,006) |
| 200 basis point increase | (17,881) | (23,623) |
| Expected credit loss rates on underlying loans | ||
| 10% adverse change | (9,135) | (10,465) |
| 20% adverse change | (18,129) | (20,397) |
| Expected prepayment rates | ||
| 10% adverse change | (1,899) | * |
| 20% adverse change | (3,783) | * |
The table below presents the fair value sensitivity of loans in consolidated securitization to adverse changes in key assumptions. The fair value of loans in consolidated securitization is not sensitive to adverse changes in discount rates and prepayment rates as such changes do not result in a material impact on the fair value as of December 31, 2024 and 2025.
| December 31, 2024 | December 31, 2025 | |
|---|---|---|
| Fair value of loans held in consolidated securitization | $102,949 | $53,762 |
| Expected credit loss rates on underlying loans | ||
| 10% adverse change | (1,799) | * |
| 20% adverse change | (3,577) | * |
The following table presents a rollforward of loans classified within Level 3 of the fair value hierarchy:
| Loans Held-for-Sale | Loans Held-for-Investment | Loans Held in Consolidated Securitization | Total | |
|---|---|---|---|---|
| Fair value at December 31, 2023 | $830,574 | $146,768 | $179,071 | $1,156,413 |
| Reclassification of loans(1) | (7,201) | 7,201 | — | — |
| Purchases and originations of loans(1)(2) | 2,224,563 | 323,069 | — | 2,547,632 |
| Sale of loans(1) | (2,342,018) | — | — | (2,342,018) |
| Purchase of loans for immediate resale(1) | 2,087,810 | — | — | 2,087,810 |
| Immediate resale of loans(1) | (2,087,810) | — | — | (2,087,810) |
| Repayments received(1) | (201,106) | (137,050) | (47,997) | (386,153) |
| Charge-offs and changes in fair value recorded in earnings | (92,687) | (59,862) | (28,125) | (180,674) |
| Other changes | (6,313) | 17,417 | — | 11,104 |
| Fair value at December 31, 2024 | $405,812 | $297,543 | $102,949 | $806,304 |
| Purchases and originations of loans(1) | 2,329,749 | 1,032,970 | — | 3,362,719 |
| Sale of loans(1) | (2,105,962) | (418,624) | — | (2,524,586) |
| Purchase of loans for immediate resale(1) | 6,765,933 | — | — | 6,765,933 |
| Immediate resale of loans(1) | (6,765,933) | — | — | (6,765,933) |
| Repayments received(1) | (193,197) | (314,827) | (37,885) | (545,909) |
| Charge-offs and changes in fair value recorded in earnings | (43,026) | (110,787) | (11,302) | (165,115) |
| Other changes | (217) | 51,356 | — | 51,139 |
| Fair value at December 31, 2025 | $393,159 | $537,631 | $53,762 | $984,552 |
(1) Represents the principal balance.
(2) Purchase activity includes an immaterial unpaid principal balance related to securitization clean-up calls during the year ended December 31, 2024.
The following table presents the aggregate fair value and aggregate principal outstanding of all loans and loans that were 90 days or more past due included in the consolidated balance sheets:
| Loans | Loans > 90 Days Past Due | |||
|---|---|---|---|---|
| December 31, | December 31, | December 31, | December 31, | |
| 2024 | 2025 | 2024 | 2025 | |
| Outstanding principal balance | $858,440 | $1,038,521 | $11,236 | $17,685 |
| Net fair value and accrued interest adjustments | (52,136) | (53,969) | (9,638) | (13,094) |
| Fair value(1)(2) | $806,304 | $984,552 | $1,598 | $4,591 |
(1) Includes $285.5 million and $367.4 million of auto loans at fair value as of December 31, 2024 and 2025, respectively, of which animmaterial amount are 90 days or more past due as of December 31, 2024 and 2025. Also includes $54.3 million and $149.5 million of HELOCs at fair value as of December 31, 2024 and 2025, respectively, of which immaterial amounts are 90 days or more past due as of December 31, 2024 and 2025, respectively.
(2) The fair value of loans in nonaccrual status wasimmaterial as of December 31, 2024 and 2025.
Line of Credit Receivable
In connection with one of its committed capital and other co-investment arrangements, the Company issued a revolving line of credit receivable to a third-party, which is classified as held-for-investment. The fair value of the line of credit receivable as of December 31, 2024 and 2025 was $56.3 million and $112.7 million, respectively.
The line of credit receivable is measured at estimated fair value using a discounted cash flow model. The model is based on the expected monthly outstanding balance of the line of credit receivable over the life of the agreement and considers the present creditworthiness of the counterparty and the difference between the market rates of return and the stated interest rate. Cash flows are discounted using an estimate of market rates of return. The fair value of the line of credit receivable also includes accrued interest.
The following table presents quantitative information about the significant unobservable inputs used for the Company’s Level 3 fair value measurements related to the line of credit receivable:
| December 31, 2024 | December 31, 2025 | |||||
|---|---|---|---|---|---|---|
| Minimum | Maximum | Weighted-Average | Minimum | Maximum | Weighted-Average | |
| Discount rate | 6.75% | 6.75% | 6.75% | 6.50% | 6.50% | 6.50% |
Discount rate–The discount rate is the rate of return used to discount future expected cash flows to arrive at a present value, which represents the fair value. The discount rate used for the projected net cash flows is the Company’s estimate of the rate of return that market participants would require when investing in this financial instrument with cash flows dependent on credit quality of the counterparty. A risk premium component is implicitly included in the discount rate to reflect the amount of compensation market participants require due to the uncertainty inherent in the instrument’s cash flows resulting from risks such as credit and liquidity of the counterparty.
The fair value sensitivity of the line of credit receivable to adverse changes in key assumptions do not result in a material impact to the fair value of the line of credit receivable as of December 31, 2024 and 2025.
The following table presents a rollforward of the line of credit receivable classified by the Company within Level 3 of the fair value hierarchy:
| Line of Credit Receivable | |
|---|---|
| Fair value at December 31, 2023 | $— |
| Issuances | 54,780 |
| Changes in fair value recorded in earnings | 1,173 |
| Changes in accrued interest | 316 |
| Fair value at December 31, 2024 | $56,269 |
| Issuances | 59,461 |
| Repayments | (5,276) |
| Changes in fair value recorded in earnings | 1,923 |
| Changes in accrued interest | 365 |
| Fair value at December 31, 2025 | $112,742 |
Assets and Liabilities related to Securitization Transactions
As of December 31, 2024 and 2025, the Company held notes receivable and residual certificates with an aggregate fair value of $22.1 million and $97.4 million, respectively, within other assets on the Company’s consolidated balance sheets. The balances consist of securitization notes and residual certificates retained from unconsolidated securitization transactions.
As of December 31, 2024 and 2025, the Company recognized payables to securitization note holders of $87.3 million and $46.5 million at fair value, respectively. The balance represents the value of the securitization notes issued and owned by third-party investors in connection with UPST 2023-2. The value of the UPST 2023-2 securitization notes and residual certificates retained by the Company is eliminated in the consolidation process.
The Company prioritizes the use of observable inputs in estimating the fair value of notes receivable and residual certificates and payable to securitization note holders when available. Fair value is corroborated using a discounted cash flow methodology. This approach uses assumptions of projected cash flows of the underlying collateral loan pools adjusted for features of these securities, which reflect the Company’s best estimates of the assumptions a market participant would use to determine fair value.
The following table presents quantitative information about the significant unobservable inputs used for the Company’s Level 3 fair value measurements related to notes receivable, residual certificates, and payable to securitization note holders:
| December 31, 2024 | December 31, 2025 | |||||
|---|---|---|---|---|---|---|
| Minimum | Maximum | Weighted-Average (1) | Minimum | Maximum | Weighted-Average (1) | |
| Notes receivable and residual certificates | ||||||
| Discount rate | 9.60% | 22.37% | 12.59% | 5.75% | 12.78% | 10.72% |
| Credit risk rate | 0.54% | 50.28% | 19.00% | 0.38% | 50.28% | 21.10% |
| Prepayment rate | 4.61% | 94.53% | 35.72% | 4.11% | 95.77% | 33.04% |
| Payable to securitization note holders | ||||||
| Discount rate | 5.96% | 10.98% | 8.52% | 6.99% | 10.40% | 9.65% |
| Credit risk rate | 0.67% | 37.70% | 15.66% | 0.67% | 35.68% | 16.12% |
| Prepayment rate | 6.73% | 89.84% | 41.51% | 6.73% | 89.84% | 40.50% |
(1)Unobservable inputs were weighted by relative fair value.
Notes Receivable and Residual Certificates
Adverse changes in discount rates, credit risk rates, or prepayment rates do not result in a material impact to the fair value of notes receivable and residual certificates as of December 31, 2024 and 2025.
Payable to Securitization Note Holders
Adverse changes in discount rates, credit risk rates, and expected prepayment rates do not result in a material impact to the fair value of payable to securitization note holders as of December 31, 2024 and 2025.
The following table presents a rollforward of the notes receivable and residual certificates and payables to securitization note holders related to securitization transactions classified by the Company within Level 3 of the fair value hierarchy:
| Notes Receivable and Residual Certificates | Payable toSecuritization NoteHolders | |
|---|---|---|
| Fair value at December 31, 2023 | $14,847 | $141,416 |
| Additions | 13,001 | — |
| Repayments and settlements | (5,917) | (55,368) |
| Changes in fair value recorded in earnings | 124 | 1,273 |
| Fair value at December 31, 2024 | $22,055 | $87,321 |
| Additions | 95,880 | — |
| Repayments and settlements | (23,051) | (40,592) |
| Changes in fair value recorded in earnings | 2,532 | (187) |
| Fair value at December 31, 2025 | $97,416 | $46,542 |
Loan Servicing Assets and Liabilities
As of December 31, 2024 and 2025, the Company’s loan servicing assets had a fair value of $27.4 million and $40.9 million, respectively, recorded within other assets on the consolidated balance sheets. As of December 31, 2024 and 2025, the Company’s loan servicing liabilities had a fair value of $1.2 million and $4.4 million, respectively, recorded within accrued expenses and other liabilities on the consolidated balance sheets.
Loan servicing assets and liabilities are measured at estimated fair value using a discounted cash flow model. The cash flows in the valuation model represent the difference between the contractual servicing fees charged to institutional investors and an estimated market servicing fee. Since contractual servicing fees are generally based on the monthly outstanding principal balance of the underlying loans, the expected cash flows in the model incorporate estimates of net losses and prepayments.
The following table presents quantitative information about the significant unobservable inputs used for the Company’s Level 3 fair value measurements for loan servicing assets and liabilities:
| December 31, 2024 | December 31, 2025 | |||||
|---|---|---|---|---|---|---|
| Minimum | Maximum | Weighted-Average (1) | Minimum | Maximum | Weighted-Average (1) | |
| Discount rate | 13.00% | 20.00% | 17.14% | 13.00% | 20.00% | 17.32% |
| Credit risk rate | 0.08% | 61.96% | 16.05% | 0.01% | 61.96% | 17.01% |
| Market-servicing rate (2)(3) | 0.62% | 3.70% | 0.62% | 0.62% | 2.69% | 0.65% |
| Prepayment rate | 2.17% | 96.90% | 36.43% | 1.96% | 96.90% | 36.50% |
(1)Unobservable inputs were weighted by relative fair value.
(2)Excludes ancillary fees that would be passed on to a third-party servicer.
(3)Expressed as a percentage of the outstanding principal balance of 1.19% -3.70% for auto loans and 0.62% for personal loans as of December 31, 2024. Expressed as a percentage of the outstanding principal balance of 1.16% -2.69% for auto loans and 0.62% -2.00% for personal loans as of December 31, 2025.
Discount rates–The discount rates are the Company’s estimate of the rates of return that market participants in servicing rights would require when investing in similar servicing rights. Discount rates for servicing rights on existing loans are adjusted to reflect the time value of money and a risk premium intended to reflect the amount of compensation market participants would require due to the uncertainty associated with these instruments’ cash flows.
Credit risk rates–The credit risk rates are the Company’s estimate of the net cumulative principal payments that will not be repaid over the entire life of a loan expressed as a percentage of the original principal amount of the loan. The assumption regarding net cumulative losses impacts the projected balances and expected terms of the loans, which are used to project future servicing revenues.
Market-servicing rates–Market-servicing rate is an estimated measure of adequate compensation for a market participant, if one was required. The rate is expressed as a fixed percentage of outstanding principal balance per annum. The estimate considers the profit that would be demanded in the marketplace to service the portfolio of outstanding loans subject to the Company’s servicing agreements.
Prepayment rates–Prepayment rates are the Company’s estimate of the cumulative principal prepayments that will occur over the entire life of a loan as a percentage of the original principal amount of the loan. The assumption regarding cumulative prepayments impacts the projected balances and expected terms of the loans, which are used to project future servicing revenues.
The table below presents the fair value sensitivity of loan servicing assets to adverse changes in market-servicing rates. The fair value of loan servicing assets and liabilities are not sensitive to adverse changes in discount rates, credit risk rates, and prepayment rates as such changes do not result in a material impact on the fair value as of December 31, 2024 and 2025. Adverse changes in market-servicing rates do not result in a material impact to the fair value of loan servicing liabilities as of December 31, 2024 and 2025.
| December 31, 2024 | December 31, 2025 | |
|---|---|---|
| Fair value of loan servicing assets | $27,439 | $40,941 |
| Expected market-servicing rates | ||
| 10% market-servicing rates increase | (6,931) | (8,402) |
| 20% market-servicing rates increase | (14,098) | (16,746) |
The following table presents a rollforward of the loan servicing assets and liabilities classified by the Company within Level 3 of the fair value hierarchy:
| Loan Servicing Assets | Loan Servicing Liabilities | |
|---|---|---|
| Fair value at December 31, 2023 | $28,092 | $2,038 |
| Sale of loans | 15,837 | 388 |
| Changes in fair value recorded in earnings | (16,490) | (1,246) |
| Fair value at December 31, 2024 | $27,439 | $1,180 |
| Sale of loans | 32,148 | 4,145 |
| Changes in fair value recorded in earnings | (18,646) | (942) |
| Fair value at December 31, 2025 | $40,941 | $4,383 |
Beneficial Interests
In connection with the committed capital and other co-investment arrangements that meet a definition of derivatives (derivative beneficial interests), the Company is obligated to make payments to the third-party or is entitled to receive payments from the third-party if credit performance on the underlying loans deviates from initial expectations set at the time of loan sale or origination, subject to a dollar cap. In the arrangements that are associated with debt-like securities with embedded derivative features, the Company makes an initial investment and is entitled to a portion of cash flows from repayments received over time on the underlying loan portfolios. These cash flows vary depending on the demonstrated credit performance relative to our expectations.
As of December 31, 2024 and 2025, the fair value of the beneficial interest assets related to these arrangements was $176.8 million and $396.2 million, respectively. As of the same dates, the fair value of the beneficial interest liabilities was $10.1 million and $5.1 million, respectively.
Beneficial interests are measured at estimated fair value using a discounted cash flow model. The discounted cash flow model sets expectations for cash flows to be received by the Company under each arrangement based on contractually-defined terms, such as total return, portfolio composition, frequency of cash distribution, and others and calculates net cash flows to be received by the Company. These net cash flows are then discounted using an estimate of market rates of return that reflect the risk premium related to those cash flows. As credit performance is demonstrated by the underlying loan portfolios, each discounted cash flow model is periodically updated to determine future cash inflows and outflows based on the latest estimated performance for the duration of each arrangement. The discounted cash flow model uses inputs discussed below that are inherently judgmental and reflect the Company’s best estimates of the assumptions a market participant would use to determine fair value of our beneficial interests.
The following table presents quantitative information about the significant unobservable inputs used for the Company’s fair value measurements of beneficial interests as of December 31, 2024 and 2025:
| December 31, 2024 | December 31, 2025 | |||||
|---|---|---|---|---|---|---|
| Minimum | Maximum | Weighted-Average(1) | Minimum | Maximum | Weighted-Average(1) | |
| Beneficial interest assets | ||||||
| Discount rate | 6.75% | 13.75% | 13.53% | 6.50% | 14.50% | 12.90% |
| Credit risk rate spread(2) | (4.00)% | 12.60% | 1.32% | (7.59)% | 13.42% | 0.89% |
| Prepayment rate spread(3) | * | * | * | (7.56)% | 15.50% | 3.60% |
| Beneficial interest liabilities | ||||||
| Discount rate | 13.75% | 13.75% | 13.75% | 13.25% | 13.25% | 13.25% |
| Credit risk rate spread(2) | (0.24)% | 18.68% | 9.78% | (5.45)% | 9.18% | 1.90% |
(2) Expressed as a percentage of cumulative net loss expectations as of the valuation date compared to the initial expectations as of the origination date or date of loan sale.
(3) Expressed as a percentage of cumulative principal prepayment expectations as of the valuation date compared to the initial expectations as of the origination date or date of loan sale.
- Prepayment rate spread was not a significant input as of December 31, 2024.
Discount rates–The discount rates are rates of return used to discount future expected cash flows to arrive at a present value, which represents the fair value. The discount rates used for the projected net cash flows are the Company’s estimates of the rates of return that market participants would require when investing in these financial instruments with cash flows dependent on credit performance of the underlying loan portfolio. A risk premium component is implicitly included in the discount rates to reflect the amount of compensation market participants require due to the uncertainty inherent in the instruments’ cash flows resulting from risks such as credit and liquidity. The Company uses two different discount rates for expected cash flows associated with demonstrated to-date credit performance and those associated with future credit performance. The difference in these rates reflects the level of uncertainty and, as a result, risk premium that would be required by market participants when investing in these instruments.
Credit risk rate spreads–Credit risk rate spreads are the measurement of estimated credit performance of underlying loan portfolios as of the reporting date in comparison to the Company’s estimates at the time of origination or sale of loans under these arrangements (“initial expectation”). More specifically, credit risk rate spreads are the difference between the initial expectation of the cumulative principal of a loan portfolio, net of average recoveries, that is estimated to not be repaid over the life of a beneficial interest (“cumulative net loss”) and the same estimate as of the reporting date. A positive credit risk rate spread indicates that the estimated cumulative net loss as of the reporting period is higher than the initial expectation for a particular portfolio. A negative credit risk rate spread indicates the opposite – the estimated cumulative net loss as of the reporting period is lower than the initial expectation. Credit risk rate spreads are expressed as a percentage of the initial expectation of the cumulative total net losses. The difference between the initial and current expectation of estimated cumulative net losses impacts the amount and the timing of cash flows the Company expects to receive on beneficial interest assets or to pay for beneficial interest liabilities.
Prepayment rate spreads– Prepayment rate spreads are the measurement of estimated prepayments on the underlying loan portfolios as of the reporting date in comparison to the Company’s initial expectation. More specifically, prepayment rate spreads are the difference between the initial expectation of cumulative principal prepayments that will occur over the life of a beneficial interest (“cumulative prepayment”) and the same estimate as of the reporting date. A positive prepayment rate spread indicates that the estimated cumulative prepayments as of the reporting period is higher than the initial expectation for a particular portfolio. A negative prepayment rate spread indicates the opposite – the estimated cumulative prepayments as of the reporting period is lower than the initial expectation. Prepayment rate spreads are expressed as a percentage of the initial expectation of the cumulative total prepayments. The difference between the initial and current expectation of estimated cumulative prepayment impacts the amount and the timing of cash flows the Company expects to receive on beneficial interest assets or to pay for beneficial interest liabilities.
The following table presents the sensitivity of beneficial interest assets and liabilities to adverse changes in key assumptions used in the valuation model as of December 31, 2024 and 2025. Adverse changes in discount rates and prepayment rates do not result in a material impact to the fair value of beneficial interest liabilities as of December 31, 2024 and 2025.
| December 31, 2024 | December 31, 2025 | |
|---|---|---|
| Fair value of beneficial interest assets | $176,848 | $396,216 |
| Discount rate | ||
| 100 basis point increase | (3,247) | (4,912) |
| 200 basis point increase | (6,384) | (9,676) |
| Expected credit risk rate spreads on underlying loans | ||
| 10% adverse change | (44,356) | (80,110) |
| 20% adverse change | (89,605) | (158,190) |
| Expected prepayment rate spreads on underlying loans | ||
| 10% adverse change | * | (7,798) |
| 20% adverse change | * | (15,244) |
| Fair value of beneficial interest liabilities | $10,089 | $5,075 |
| Expected credit risk rate spreads on underlying loans | ||
| 10% adverse change | 4,720 | 22,409 |
| 20% adverse change | 10,259 | 44,420 |
The following table presents a rollforward of beneficial interest assets and liabilities:
| Beneficial Interest Assets | Beneficial Interest Liabilities | |
|---|---|---|
| Fair value at December 31, 2023 | $41,012 | $4,221 |
| Acquisition of beneficial interests | 148,448 | — |
| Settlement of beneficial interests | (7,461) | (6,700) |
| Changes in fair value recorded in earnings | (5,151) | 12,568 |
| Fair value at December 31, 2024 | $176,848 | $10,089 |
| Acquisition of beneficial interests | 326,870 | 5 |
| Settlement of beneficial interests, net | (140,686) | (21,598) |
| Changes in fair value recorded in earnings | 33,184 | 16,579 |
| Fair value at December 31, 2025 | $396,216 | $5,075 |
Trailing Fee Liabilities
The Company pays certain lending partners monthly trailing fees based on the amount and timing of principal and interest payments made by borrowers of the underlying loans. The Company held trailing fee liabilities of $4.6 million and $5.8 million as of December 31, 2024 and 2025, respectively.
The discounted cash flow methodology, which is used to estimate the fair value of trailing fee liabilities, uses the same projected net cash flows as the underlying loans. The fair valuation methodology considers projected prepayments and historical defaults, losses and recoveries to project future losses and net cash flows of the underlying loans. Net cash flows are discounted using an estimate of market rates of return.
The following table presents quantitative information about the significant unobservable inputs used for the Company’s Level 3 fair value measurements for trailing fee liabilities:
| December 31, 2024 | December 31, 2025 | |||||
|---|---|---|---|---|---|---|
| Minimum | Maximum | Weighted-Average (1) | Minimum | Maximum | Weighted-Average (1) | |
| Discount rate | 9.55% | 22.37% | 12.54% | 5.00% | 14.78% | 10.15% |
| Credit risk rate | 0.02% | 88.53% | 18.97% | 0.04% | 67.59% | 19.48% |
| Prepayment rate | 1.51% | 95.80% | 35.50% | 1.52% | 95.77% | 34.59% |
The fair value sensitivity of trailing fee liabilities to adverse changes in key assumptions do not result in a material impact to the fair value of trailing fee liabilities as of December 31, 2024 and 2025.
The following table presents a rollforward of trailing fee liabilities classified by the Company within Level 3 of the fair value hierarchy:
| Trailing Fee Liabilities | |
|---|---|
| Fair value at December 31, 2023 | $4,251 |
| Issuances | 3,194 |
| Repayments and settlements | (3,003) |
| Changes in fair value recorded in earnings | 172 |
| Fair value at December 31, 2024 | $4,614 |
| Issuances | 4,043 |
| Repayments and settlements | (2,900) |
| Changes in fair value recorded in earnings | 4 |
| Fair value at December 31, 2025 | $5,761 |
- Goodwill and Intangible Assets
Goodwill
During the year ended December 31, 2024 and 2025, there were no changes in the carrying amount of goodwill of $67.1 million on the Company’s consolidated balance sheets.
Intangible Assets
Acquired intangible assets subject to amortization consist of customer relationships, and are recorded net of amortization and included within other assets on the consolidated balance sheets. The gross and net carrying values and accumulated amortization are as follows:
| December 31, 2024 | December 31, 2025 | |||||
|---|---|---|---|---|---|---|
| Gross Carrying Value | Accumulated Amortization | Net Carrying Value | Gross Carrying Value | Accumulated Amortization | Net Carrying Value | |
| Customer relationships | $13,700 | $(4,281) | $9,419 | $13,700 | $(5,423) | $8,277 |
Amortization expense was $4.3 million for the year ended December 31, 2023 andimmaterial for the years ended December 31, 2024 and 2025.
Expected future amortization expense for intangible assets is as follows:
| 2026 | $1,142 |
| 2027 | 1,142 |
| 2028 | 1,142 |
| 2029 | 1,142 |
| 2030 | 1,142 |
| Thereafter | 2,567 |
| Total | $8,277 |
- Balance Sheet Components
Other Assets
Other assets consisted of the following:
| December 31, 2024 | December 31, 2025 | |
|---|---|---|
| Notes receivable and residual certificates (at fair value)(1)(3) | 22,055 | 97,416 |
| Receivables | 48,233 | 46,647 |
| Loan servicing assets (at fair value)(1) | 27,439 | 40,941 |
| Prepaid expenses | 28,830 | 39,658 |
| Other assets | 19,321 | 17,379 |
| Intangible assets, net(2) | 9,431 | 8,289 |
| Deposits | 5,185 | 5,057 |
| Total other assets | $160,494 | $255,387 |
(1)Refer to “Note 5. Fair Value Measurement”for further information.
(2)Refer to “Note 6. Goodwill and Intangible Assets”for further information.
(3)Refer to“Note 8. Borrowings”for further information on securitization notes pledged as collateral as part of the risk retention financing facility.
Receivables represent amounts recognized as revenue but not yet collected in relation to servicing and other agreements with institutional investors and lending partners.
Property, Equipment, and Software, Net
Property, equipment, and software, net consisted of the following:
| December 31, 2024 | December 31, 2025 | |
|---|---|---|
| Internally developed software | $68,481 | $95,923 |
| Leasehold improvements | 15,069 | 15,519 |
| Computer and networking equipment | 6,069 | 6,358 |
| Furniture and fixtures | 4,795 | 4,795 |
| Total property, equipment, and software | 94,414 | 122,595 |
| Accumulated depreciation and amortization | (55,401) | (78,421) |
| Total property, equipment, and software, net | $39,013 | $44,174 |
For the years ended December 31, 2023, 2024 and 2025, depreciation and amortization expense on property, equipment, and software was $20.6 million, $18.6 million, and $23.7 million, respectively.
Capitalized internally developed software balances, net of accumulated amortization, were $31.0 million and $38.5 million as of December 31, 2024 and 2025, respectively. The Company recognized $2.6 million of impairment charges to internally developed software as a result of the January 2023 Plan during the year ended December 31, 2023. Refer to “Note 15. Reorganization Expenses” for more information. The Company recognized immaterial impairment charges to internally developed software during the years ended December 31, 2024 and 2025.
Accrued Expenses and Other Liabilities
Accrued expenses and other liabilities consisted of the following:
| December 31, 2024 | December 31, 2025 | |
|---|---|---|
| Accrued expenses | $37,781 | $68,232 |
| Accrued payroll | 64,514 | 49,275 |
| Accounts payable | 12,381 | 31,981 |
| Other liabilities | 3,241 | 6,788 |
| Trailing fee liability (at fair value) | 4,614 | 5,761 |
| Beneficial interest liabilities (at fair value) | 10,089 | 5,075 |
| Loan servicing liabilities (at fair value) | 1,180 | 4,383 |
| Total accrued expenses and other liabilities | $133,800 | $171,495 |
- Borrowings
The following table presents the aggregate principal outstanding of all borrowings that are included in the consolidated balance sheets:
| December 31, 2024 | December 31, 2025 | |
|---|---|---|
| Warehouse credit facilities | $195,605 | $97,333 |
| Risk retention financing facility | — | 75,647 |
| Convertible senior notes | 1,230,379 | 1,687,794 |
| Total payments due | 1,425,984 | 1,860,774 |
| Unamortized debt discount | (23,816) | (31,629) |
| Total borrowings | $1,402,168 | $1,829,145 |
The following table summarizes the aggregate amount of maturities of all borrowings:
| 2026 | $66,544 |
| 2027 | — |
| 2028 | 97,332 |
| 2029 | 431,250 |
| 2030 | 500,000 |
| Thereafter | 765,648 |
| Total | $1,860,774 |
Warehouse Credit Facilities
The following table presents the details of the Company’s revolving warehouse credit facilities:
| December 31, 2024 · December 31, 2025 | |||||||
|---|---|---|---|---|---|---|---|
| Stated Interest Rate(1) | Termination and Maturity(2) | Total Borrowing Capacity(3) | Collateral(4) | Outstanding Borrowings | Collateral(4) | Outstanding Borrowings | |
| Upstart Auto Warehouse Trust | Benchmark rate + 3.0% | April 2025 | $— | $167,166 | $23,228 | $— | $— |
| Upstart Auto Warehouse Trust 2 | Benchmark rate + 0% - 4.0% | August 2026 and August 2027 | 150,000 | 19,396 | 11,353 | 3 | 1 |
| Upstart Loan Trust | Benchmark rate + 2.4% - 3.8% | June 2027 and June 2028 | 325,000 | 74,541 | 34,217 | 56,255 | 23,025 |
| Upstart Small Dollar Loan Trust | Benchmark rate + 5.5% | June 2027 and June 2028 | 100,000 | 108,980 | 61,807 | 128,973 | 74,307 |
| Upstart High Yield Loan Trust | Benchmark rate + 2.8% | December 2025 | — | 87,493 | 65,000 | — | — |
| Total | $575,000 | $457,576 | $195,605 | $185,231 | $97,333 | ||
(1)The interest rates on our warehouse credit facilities are floating and designed as a reference rate plus a spread. Reference rates include the Compounded Secured Overnight Financing Rate, weighted-average cost of commercial paper notes issued by the lender, and the federal funds rate. The stated interest rate excludes unused commitment fees which range from 0.5% to 1.0%. The undrawn fee for Upstart Small Dollar Loan Trust is the dollar amount of interest and fees that would have been due if the daily average aggregate outstanding principal balance was equal to 75% of the then-applicable borrowing base.
(2)The first date represents the final date the Company may borrow up to the maximum capacity under the warehouse. The second date is the maturity date, when the outstanding principal amount, together with accrued and unpaid interest will be due and payable in full.
(3)Total capacity is as of December 31, 2025. Upstart Small Dollar Loan Trust has $100.0 million of uncommitted capacity and Upstart Loan Trust has $150.0 million of uncommitted capacity out of the $325.0 million total. As of December 31, 2025, the Upstart Auto Warehouse Trust facility and the Upstart High Yield Loan Trust facility have been terminated.
(4)Represents the aggregate restricted cash and unpaid principal balance of loans pledged as collateral.
On June 14, 2024, Upstart Auto Warehouse Trust began its amortization period and on April 15, 2025, the facility was fully amortized and repaid in line with expectations. Following the full amortization and repayment, the Company terminated the facility.
On June 27, 2025, Upstart Loan Trust amended its credit agreement to extend the maturity date to June 15, 2028. Additionally, the applicable margin on borrowing during the revolving period was reduced to 2.4% from 2.8%.
On August 7, 2025, Upstart Auto Warehouse Trust 2 amended its credit agreement to extend the maturity date to August 7, 2027. Additionally, the total borrowing capacity increased from $50.0 million to $150.0 million.
On December 29, 2025, Upstart High Yield Loan Trust was fully repaid and the Company terminated the facility.
The Company’s warehouse credit facilities contain certain financial covenants. On January 15, 2026, the Company obtained a waiver under the Upstart Loan Trust warehouse facility related to breaches of certain financial covenants for the December 2025 collection period. As of December 31, 2025, the Company was in compliance with all applicable covenants for its other warehouse credit facilities.
Risk Retention Financing Facility
In June 2025, the Company entered into a $100.0 million risk retention financing facility to finance certain securitization notes receivable it retained in a capacity of the risk retention sponsor under applicable risk retention regulations. Under this facility, the Company pledged the securitization notes receivable as collateral. The facility’s maturity aligns with the stated maturities of the underlying notes, which range from 2026 to 2035. The facility is accounted for as a secured borrowing.
As of December 31, 2025, the outstanding balance of the facility was $75.6 million, presented within borrowings on the consolidated balance sheets, and the fair value of the securitization notes receivable pledged was $75.9 million, which is presented within other assets on the consolidated balance sheets. The financing bears interest at the weighted-average coupon of the pledged securities plus a 0.40% spread.
Pledged collateral levels are monitored and maintained at an agreed-upon percentage of the outstanding borrowings during the life of the borrowing. In the event of a decline in the fair value of the pledged collateral, the Company may be required to transfer cash or pledge additional securities under this facility.
Convertible Senior Notes
In August 2021, the Company issued $661.3 million in aggregate principal amount of 0.25% convertible senior notes due 2026 (the “2026 Notes”). In September 2024, the Company issued $431.3 million in aggregate principal amount of 2.00% convertible senior notes due 2029 (the “2029 Notes”). In November 2024, the Company issued $500.0 million in aggregate principal amount of 1.00% convertible senior notes due 2030 (the “2030 Notes”). In August 2025, the Company issued $690.0 million in aggregate principal amount of 0% convertible senior notes due 2032 (the “2032 Notes” and, together with the 2026 Notes, 2029 Notes and 2030 Notes, the “Notes”).
Concurrently with the issuance of the 2029 Notes and the 2032 Notes, the Company repurchased portions of the 2026 Notes. In the third quarter of 2024, the Company used approximately $302.4 million of the netproceeds from the offering of the 2029 Notes to repurchase approximately $334.2 million in aggregate principal amount of the outstanding 2026 Notes in individually negotiated transactions and additionally repurchased approximately $27.9 million of the outstanding 2026 Notes in open-market purchases. In August 2025, the Company used approximately $224.2 million of the net proceeds from the offering of the 2032 Notes to repurchase approximately $232.6 million in aggregate principal amount of the outstanding 2026 Notes in individually negotiated transactions.
The repurchases of the 2026 Notes were accounted for as a debt extinguishment. The difference between the consideration paid to repurchase the 2026 Notes and the carrying value of the 2026 Notes, resulted in a gain on debt extinguishment of $33.4 million and $7.2 million separately reportedon the consolidated statement of operations and comprehensive income (loss) during the years ended December 31, 2024 and 2025, respectively. The partial extinguishments did not result in any changes to the terms of the 2026 Notes.
The table below presents the activity of the Notes during the year ended December 31, 2025:
| Principal balance of Notes outstanding as of December 31, 2024 | $1,230,379 |
|---|---|
| Issuance of 2032 Notes | 690,000 |
| Repurchases of 2026 Notes | (232,585) |
| Principal balance of Notes outstanding as of December 31, 2025 | $1,687,794 |
Each series of Notes is governed by its respective indenture (each, an “Indenture”), and represents senior unsecured obligations of the Company. The 2026 Notes mature on August 15, 2026, the 2029 Notes mature on October 1, 2029, the 2030 Notes mature on November 15, 2030, and the 2032 Notes mature on February 15, 2032, unless such Notes are earlier converted, redeemed, or repurchased in accordance with their terms. The Company may redeem for cash all or any portion of the Notes, at its option, on or after August 20, 2024, in the case of the 2026 Notes, on or after October 6, 2027, in the case of the 2029 Notes, on or after November 20, 2027, in the case of the 2030 Notes, and on or after August 20, 2028, in the case of the 2032 Notes, if the last reported sale price of the Company’s common stock has been at least 130% of the conversion price for the Notes of the applicable series then in effect for at least 20 trading days (whether or not consecutive) during any 30 consecutive trading-day period (including the last trading day of such period) ending on, and including, the trading day immediately preceding the date on which the Company provides a notice of redemption for the Notes of such series at a redemption price equal to 100% of the principal amount of the Notes of such series to be redeemed, plus any accrued and unpaid interest (or special interest, if any, in the case of the 2032 Notes) to, but excluding, the redemption date.
The following table presents details of the Notes:
| Interest Rate | Initial Conversion Rate per $1,000 Principal | Initial Conversion Price | Conversion Date | |
|---|---|---|---|---|
| 2026 Notes | 0.25%; payable semiannually on February 15 and August 15 | 3.5056 | $285.26 | May 15, 2026 |
| 2029 Notes | 2.00%; payable semiannually on April 1 and October 1 | 21.9029 | $45.66 | July 1, 2029 |
| 2030 Notes | 1.00%; payable semiannually on May 15 and November 15 | 10.8702 | $91.99 | August 15, 2030 |
| 2032 Notes | 0% | 12.1215 | $82.50 | November 15, 2031 |
Holders of the Notes may convert their Notes at their option any time prior to the close of business on the business day immediately preceding May 15, 2026, in the case of the 2026 Notes; July 1, 2029, in the case of the 2029 Notes; August 15, 2030, in the case of the 2030 Notes; and November 15, 2031, in the case of the 2032 Notes, only under the following circumstances:
(1) during any calendar quarter commencing after December 31, 2021, in the case of the 2026 Notes, December 31, 2024, in the case of the 2029 Notes, March 31, 2025, in the case of the 2030 Notes and December 31, 2025, in the case of the 2032 Notes, (and only during such calendar quarter), if the last reported sale price of the Company’s common stock for at least 20 trading days (whether or not consecutive) during a period of 30 consecutive trading days ending on, and including, the last trading day of the immediately preceding calendar quarter is greater than or equal to 130% of the applicable conversion price for the respective Notes on each applicable trading day;
(2) during thefive business-day period after anyfive consecutive trading-day period in which the trading price per $1,000 principal amount of the applicable series of Notes for each trading day of such five consecutive trading-day period was less than 98% of the product of the last reported sale price of the Company’s common stock and the conversion rate of the respective Notes on each such trading day;
(3) if the Company calls any or all of the Notes of the applicable series for redemption, at any time prior to the close of business on the second scheduled trading day immediately preceding the redemption date; or
(4) upon the occurrence of specified corporate events.
On or after May 15, 2026, in the case of the 2026 Notes, July 1, 2029, in the case of the 2029 Notes, August 15, 2030, in the case of the 2030 Notes, and November 15, 2031, in the case of the 2032 Notes, holders of the Notes of the applicable series may surrender all or any portion of their Notes of such series for conversion at any time prior to the close of business on the second scheduled trading day immediately preceding the applicable maturity date regardless of the foregoing conditions. Upon conversion, the Company will pay or deliver, as the case may be, either cash, shares of common stock or a combination of cash and shares of common stock, at its election.
The conversion price for each series of Notes will be subject to adjustment if certain events occur. In addition, following certain corporate events that may occur prior to the applicable maturity date or following the Company’s issuance of a notice of redemption for a series of Notes, the Company may be required to increase the conversion rate for the holder of the Notes of such series who elect to convert such Notes in connection with such corporate event or during the related redemption period in certain circumstances. Additionally, upon the occurrence of a corporate event that constitutes a “fundamental change” pursuant to the applicable Indenture, holders of the applicable series of Notes may require the Company to repurchase for cash all or a portion of such Notes at a repurchase price equal to 100% of the principal amount of the Notes of such series to be redeemed plus accrued and unpaid interest (or special interest, if any, in the case of the 2032 Notes) to, but excluding, the fundamental change repurchase date.
The Company accounted for the issuance of each series of the Notes as a single liability at par as the conversion feature of each series of Notes does not require bifurcation as a derivative under ASC 815 and the Notes were not issued at a substantial premium. Debt issuance costs related to the 2026 Notes, 2029 Notes, 2030 Notes and 2032 Notes totaled $15.7 million, $10.4 million, $11.8 million, and $14.4 million respectively, which are amortized to interest expense under the effective interest method over the contractual term. Theeffective interest rate of the 2026 Notes, 2029 Notes, 2030 Notes and 2032 Notes is 0.7%,2.5%,1.4%, and 0.3% respectively. The Company recorded immaterial, $4.5 million, and $14.2 million coupon interest expense related to the Notes for the years ended December 31, 2023, 2024 and 2025, respectively. The Company also recorded $3.1 million, $3.2 million, andimmaterial amount of amortization of debt issuance costs within other income, net on the consolidated statements of operations and comprehensive income (loss) for the years ended December 31, 2023, 2024 and 2025, respectively. Accrued interest expenses related to the Notes were $3.3 million andimmaterial as of December 31, 2024 and 2025, respectively.
The following table presents the components of the Notes as of December 31, 2024 and December 31, 2025:
| December 31, 2024 | December 31, 2025 | |||||||
|---|---|---|---|---|---|---|---|---|
| Principal Amount | UnamortizedDebtDiscount | NetCarryingAmount | FairValue | Principal Amount | UnamortizedDebtDiscount | NetCarryingAmount | FairValue | |
| 2026 Notes | $299,129 | $(2,339) | $296,790 | $272,727 | $66,544 | $(209) | $66,335 | $63,958 |
| 2029 Notes | 431,250 | (9,932) | 421,318 | 675,732 | 431,250 | (7,933) | 423,317 | 566,500 |
| 2030 Notes | 500,000 | (11,545) | 488,455 | 488,015 | 500,000 | (9,643) | 490,357 | 461,614 |
| 2032 Notes | — | — | — | — | 690,000 | (13,613) | 676,387 | 573,687 |
| Total | $1,230,379 | $(23,816) | $1,206,563 | $1,436,474 | $1,687,794 | $(31,398) | $1,656,396 | $1,665,759 |
The estimated fair value repres ents Level 2 valuations in the fair value hierarchy and was determined based on the estimated or actual bids and offers of the Notes in an over-the-counter market.
Capped Call Transactions
In connection with the issuance of the 2026 Notes, the 2029 Notes, and the 2032 Notes, the Company entered into separate privately negotiated capped call instruments with certain financial institutions (the “2026 Capped Calls,” with respect to the 2026 Notes, the “2029 Capped Calls,” with respect to the 2029 Notes, the “2032 Capped Calls,” with respect to the 2032 Notes, and the 2026 Capped Calls together with the 2029 Capped Calls and the 2032 Capped Calls, the “Capped Calls”).
The Capped Calls are generally expected to reduce the potential dilution to the Company’s common stock upon any conversion of the 2026 Notes, 2029 Notes and 2032 Notes, as applicable, and/or offset any cash payments the Company is required to make in excess of the principal amount of such converted 2026 Notes, 2029 Notes, and 2032 Notes as the case may be, in the event the market price per share of the Company’s common stock, as measured under the terms of the Capped Calls, is greater than the strike price of the Capped Calls, with such reduction and/or offset subject to a cap. If, however, the market price per share of the common stock, as measured under the terms of the Capped Calls, exceeds the cap price of the Capped Calls, there would be dilution and/or there would not be an offset of such potential cash payments, in each case, to the extent that such market price per share of the Company’s common stock exceeds the cap price of the Capped Calls.
The following table sets forth other key terms for the Capped Calls related to each series of Notes:
| Initial Strike Price per Share, Subject to Certain Adjustments | Initial Cap Price per Share, Subject to Certain Adjustments | Shares of Common Stock Covered, Subject to Anti-Dilution Adjustments(in millions) | Final Expiration Date | |
|---|---|---|---|---|
| 2026 Capped Calls | $285.26 | $400.36 | 0.2 | August 15, 2026 |
| 2029 Capped Calls | $45.66 | $70.24 | 9.4 | September 27, 2029 |
| 2032 Capped Calls | $82.50 | $126.92 | 8.4 | February 15, 2032 |
The Capped Calls were determined to be freestanding financial instruments that meet the criteria for classification in equity; as such, the Capped Calls were recorded as a reduction of additional paid-in capital within stockholders’ equity.
In the third quarter of 2024 and 2025, in connection with the partial repurchases of the 2026 Notes described above, the Company entered into agreements to terminate portions of the 2026 Capped Calls corresponding to the aggregate principal amounts of the 2026 Notes repurchased. As a result of these partial terminations, the Company received immaterial cash payments which were recorded as an increase to additional paid-in capital within stockholders’ equity.
- Stockholders' Equity
Common Stock Reserved for Future Issuance
In December 2020, the Company's amended and restated certificate of incorporation became effective, which authorizes the issuance of 700,000,000 shares of common stock with a par value of $0.0001 per share. Shares of common stock reserved for issuance, on an as-converted basis, are as follows:
| December 31, 2024 | December 31, 2025 | |
|---|---|---|
| Options issued and outstanding | 10,709,898 | 9,204,983 |
| Restricted stock units outstanding | 3,703,631 | 2,276,156 |
| Shares available for future issuance under 2020 plan | 7,669,374 | 10,922,232 |
| Shares available for issuance under employee stock purchase plan | 3,425,952 | 4,140,207 |
| Total | 25,508,855 | 26,543,578 |
Share Repurchase Program
In February 2022, the Board of Directors authorized the Company to purchase up to $400.0 million of common stock of the Company. The Company may repurchase shares from time to time through open market purchases, in privately negotiated transactions or by other means, including through the use of trading plans intended to qualify under Rule 10b5-1. The repurchase program does not obligate the Company to acquire any particular amount of its common stock, and may be suspended or terminated by the Company at any time at its discretion without prior notice.
The Company records share repurchases on the settlement date. Repurchased shares are subsequently retired and returned to the status of authorized but unissued. The Company’s policy for share retirements is to allocate the excess between par value and the repurchase price, including costs and fees, to additional paid-in capital. During the year ended December 31, 2025, the Company madeno repurchases of common stock. As of December 31, 2025, $222.1 million remains available for future purchases of our common stock under the share repurchase program.
At-the-Market Program
On February 14, 2025, in connection with the commencement of an “at the market” offering program, the Company entered into a sales agreement (the “Sales Agreement”) with BTIG, LLC, under which the Company may offer and sell, from time to time, up to an aggregate of $500.0 million of its common stock. The Company will pay a commission of up to 2% of the gross proceeds of shares sold, if any, under the Sales Agreement and intends to use the net proceeds from sales for working capital and general corporate purposes. As of December 31, 2025, no shares were issued under the program.
Equity Incentive Plans
In 2012, the Company adopted the Equity Incentive Plan (“2012 Equity Incentive Plan”) authorizing the granting of incentive stock options (“ISOs”) and non-statutory stock options (“NSOs”) to eligible participants.
Under the 2012 Equity Incentive Plan, the exercise price of an ISO and NSO shall not be less than 100% of the estimated fair value of the shares on the date of grant, as determined by the Board of Directors. The exercise price of an ISO granted to a 10% stockholder shall not be less than 110% of the estimated fair value of the shares on the date of grant, as determined by the Board of Directors. Options generally vest over four years and are exercisable for up to 10 years after the date of grant if the employee provides service to the Company for at least three years.
In October 2020, our Board of Directors adopted, and in November 2020 our Board of Directors amended and our stockholders approved, our 2020 Equity Incentive Plan (“2020 Equity Incentive Plan”), which was effective on December 14, 2020. The Company terminated the 2012 Equity Incentive Plan immediately prior to effectiveness of the 2020 Equity Incentive Plan with respect to the grant of future awards. However, our 2012 Equity Incentive Plan continues to govern the terms and conditions of the outstanding awards granted under our 2012 Equity Incentive Plan.
The 2020 Equity Incentive Plan authorizes granting of ISOs, NSOs, stock appreciation rights, restricted stock, RSUs, and performance awards to eligible participants. In addition, the 2020 Equity Incentive Plan also includes any shares subject to awards granted under our 2012 Equity Incentive Plan that, on or after December 15, 2020, expire or otherwise terminate without having been exercised or issued in full, are tendered to or withheld by us for payment of an exercise price or for satisfying tax withholding obligations, or are forfeited to or repurchased by us due to failure to vest. The maximum number of shares that may be added to the 2020 Equity Incentive Plan pursuant to outstanding awards under the 2012 Equity Incentive Plan is 15,000,000 shares. The number of shares available for issuance under our 2020 Equity Incentive Plan also includes an annual increase on the first day of each fiscal year beginning with 2021 in an amount equal to the lesser of 15,000,000 shares or 5% of the outstanding shares of our common stock on the last day of our immediately preceding fiscal year.
Stock Options
The following table summarizes stock option activity for the year ended December 31, 2025:
| Number of Options | Weighted-Average Exercise Price Per Share | Weighted-Average Remaining Contractual Life (years) | Aggregate Intrinsic Value | |
|---|---|---|---|---|
| Balances at December 31, 2024 | 10,709,898 | $18.35 | 5.9 | $495,359 |
| Options granted | 791,546 | 66.21 | ||
| Options exercised | (1,580,432) | 10.67 | ||
| Options cancelled and forfeited | (716,029) | 26.98 | ||
| Balances at December 31, 2025 | 9,204,983 | 23.11 | 5.3 | 247,040 |
| Options exercisable – December 31, 2025 | 7,187,200 | 19.57 | 4.6 | 215,603 |
| Options vested and expected to vest – December 31, 2025 | 9,196,475 | $23.09 | 5.3 | $246,960 |
The aggregate intrinsic value is calculated as the difference between the exercise price of the underlying awards and the fair value of the Company’s stock as of December 31, 2025. The aggregate intrinsic value of options exercised for the years ended December 31, 2023, 2024 and 2025 was $28.9 million, $139.6 million, and $84.6 million respectively. The weighted-average grant date fair value of options granted during the years ended December 31, 2023, 2024 and 2025 was $8.19, $15.11 and $35.61 per share, respectively. The total fair value of options vested for the years ended December 31, 2023, 2024 and 2025 was $34.7 million,$30.5 million, and $21.9 million, respectively.
As of December 31, 2025, total unrecognized stock-based compensation expense related to unvested stock options was $35.2 million, which is expected to be recognized over a remaining weighted-average period of 1.9 years.
Restricted Stock Units
The Company grants RSUs to employees and non-employees. RSUs vest upon satisfaction of a service-based condition, which is generally satisfied overone tofour years. The following table summarizes RSU activity for the year ended December 31, 2025:
| Number of Shares | Weighted-Average Grant Date Fair Value Per Share | |
|---|---|---|
| Unvested at December 31, 2024 | 3,703,631 | $33.46 |
| RSUs granted | 2,021,781 | 62.12 |
| RSUs vested | (2,763,508) | 41.78 |
| RSUs cancelled and forfeited | (685,748) | 38.06 |
| Unvested at December 31, 2025 | 2,276,156 | $47.43 |
As of December 31, 2025, total unrecognized stock-based compensation expense related to outstanding unvested RSUs was $78.2 million, which is expected to be recognized over a remaining weighted-average period of 1.1 years.
Performance-based Restricted Stock Units
On February 24, 2023, the Company’s Compensation Committee of the Board of Directors approved the cancellation of PRSUs that may be settled for 687,500 shares of the Company’s common stock granted to an executive in February 2022.
At the time the PRSUs were granted, the PRSUs were intended to be the executive’s primary compensation through calendar year 2029. The Compensation Committee later determined that the grant no longer provided the intended retention and incentive value to the executive and believed it was in the best interest of the Company and its stockholders to cancel the PRSUs in exchange for the reinstatement of the executive’s cash compensation.
Compensation expense associated with the PRSUs was recognized using the straight-line attribution method for each of thenine vesting tranches over the respective derived service period. The weighted-average grant date fair value using the Monte Carlo simulation was $68.76 per share. The Company recognizes stock-based compensation expense for awards subject to market-based vesting conditions regardless of whether these conditions will be achieved or not, and stock-based compensation expense for any such awards is not reversed if the market condition is not met. The cancellation of the grant was treated by the Company as a settlement for no consideration and remaining unrecognized compensation expense of $39.0 million associated with the grant was accelerated and recorded by the Company as part of engineering and product development expense on the consolidated statements of operations and comprehensive income (loss) during the year ended December 31, 2023.
There wereno PRSUs outstanding during the years ended December 31, 2024 and 2025.
2020 Employee Stock Purchase Plan
Our ESPP provides for consecutivesix-month offering periods. The offering periods are scheduled to start on the first trading day on or after February 15 and August 15 of each year. The ESPP permits participants to purchase shares in the amount of 85% of the lower of the fair market value of our shares of common stock on the first trading day of the offering period or on the exercise date. During the year ended December 31, 2025,219,818 shares of common stock were purchased under the ESPP.
As of December 31, 2025, total unrecognized stock-based compensation expense related to the ESPP wasimmaterial.
Fair Value of Awards Granted
In determining the fair value of stock-based awards, the Company uses a Black-Scholes option-pricing model for its options granted and ESPP purchase rights. The inputs used for estimating the fair values of options and ESPP purchase rights granted during the period include:
Fair Value of Common Stock–The fair value of the Company’s common stock is determined by the closing price, on the date of grant, of its common stock, which is traded on the Nasdaq Global Select Market.
Expected Term–The expected term represents the period that the Company’s stock options and ESPP purchase rights are expected to be outstanding. We estimate the expected term for stock options based on the simplified method, which is the weighted-average time to vesting and the contractual maturity. For ESPP, the expected term represents the term from the first day of the offering period to the purchase date.
Volatility–The Company estimates the expected volatility for stock options based on the weighted-average historical volatility of the Company’s common stock and the average volatility for comparable publicly-traded companies, over a period equal to the expected term. Previously, expected volatility was based solely on historical volatility of comparable publicly-traded peer companies. For ESPP, the expected volatility is estimated using historical volatility of the Company’s common stock over the expected term.
Risk-free Interest Rate–The risk-free interest rate assumption is based on the U.S. Treasury zero coupon issues in effect at the time of grant for periods corresponding with the expected term of the option.
Dividends–The Company has never paid dividends on its common stock and does not anticipate paying dividends on common stock for the foreseeable future. Therefore, the Company uses an expected dividend yield ofzero.
The following assumptions were used to estimate the fair value of options granted:
| Year Ended December 31, | |||
|---|---|---|---|
| 2023 | 2024 | 2025 | |
| Expected term (in years) | 5.1 – 7.0 | 5.1 – 7.0 | 5.1 – 7.0 |
| Expected volatility | 50.96% – 53.76% | 50.32% – 67.85% | 50.66% – 67.40% |
| Risk-free interest rate | 3.45% – 4.86% | 3.76% – 4.43% | 3.72% – 4.09% |
| Dividend yield | —% | —% | —% |
The following assumptions were used to estimate the fair value of ESPP purchase rights:
| Year Ended December 31, | |||
|---|---|---|---|
| 2023 | 2024 | 2025 | |
| Expected term (in years) | 0.5 | 0.5 | 0.5 |
| Expected volatility | 97.74% – 131.05% | 88.37% – 96.69% | 95.30% – 99.09% |
| Risk-free interest rate | 4.97% – 5.55% | 5.04% – 5.30% | 4.12% – 4.34% |
| Dividend yield | —% | —% | —% |
Stock-Based Compensation
The Company recorded stock-based compensation in the following expense categories in its consolidated statements of operations and comprehensive income (loss) for employees and non-employees:
| Year Ended December 31, | |||
|---|---|---|---|
| 2023 | 2024 | 2025 | |
| Sales and marketing | $8,166 | $11,705 | $12,679 |
| Customer operations | 10,683 | 7,038 | 7,200 |
| Engineering and product development | 110,381 | 70,786 | 65,691 |
| General, administrative, and other | 45,809 | 43,871 | 46,380 |
| Total | $175,039 | $133,400 | $131,950 |
- Leases
The Company’s operating leases expire between 2026 and 2029 and are primarily for its corporate headquarters in San Mateo, California, as well as additional office space in Columbus, Ohio and Austin, Texas. Certain leases have rent abatement, escalating rent payment provisions, lease renewal options, and tenant allowances. Rent expense is recognized on a straight-line basis over the non-cancelable lease term, except when it is reasonably certain that the renewal option will be exercised.
During the year ended December 31, 2025, the Company amended its operating lease for its San Mateo office space, which revised the remaining lease term and future lease payments. The amendment resulted in a remeasurement of the related operating lease liability and a corresponding adjustment to the right-of-use asset, reducing both balances by $15.4 million.
Future minimum lease payments are as follows:
| 2026 | $10,607 |
| 2027 | 5,558 |
| 2028 | 4,441 |
| 2029 | 2,990 |
| Total undiscounted lease payments | 23,596 |
| Less: Present value adjustment | (2,447) |
| Operating lease liabilities | $21,149 |
As of December 31, 2025, the Company has entered into leases that have not yet commenced with estimated total future lease payments of $66.2 million. These leases are expected to commence during the fiscal year of 2026, with initial lease terms ranging from 8 to 11 years.
The Company had immaterial finance lease expense during the year ended December 31, 2023 and no finance lease expense during the year ended December 31, 2024 and 2025. The Company’s operating lease expense consists of rent and variable lease payments. Variable lease payments such as common area maintenance and parking fees, were included in operating expenses. Rent expense for the Company’s short-term leases was immaterial during the periods presented. The Company had immaterial sublease income during the years ended December 31, 2023, 2024 and 2025. Operating lease expense was as follows:
| Year Ended December 31, | |||
|---|---|---|---|
| 2023 | 2024 | 2025 | |
| Rent expense | $15,766 | $14,198 | $14,031 |
| Variable lease payments | $4,067 | $3,776 | $4,030 |
Supplemental cash flow and non-cash information related to the Company’s operating leases was as follows:
| Year Ended December 31, | |||
|---|---|---|---|
| 2023 | 2024 | 2025 | |
| Cash paid for amounts included in the measurement of lease liabilities | $22,014 | $14,396 | $15,902 |
| Adjustments to operating lease right-of-use assets due to modification and other reassessment events | $(19,865) | $— | $(15,397) |
Supplemental balance sheet information related to the Company’s operating leases was as follows:
| December 31, 2024 | December 31, 2025 | |
|---|---|---|
| Weighted-average remaining lease term (in years) | 3.60 | 2.70 |
| Weighted-average discount rate | 5.22% | 7.13% |
- Commitments and Contingencies
Commitments
The Company has loan purchase obligations under the Company’s loan agreements with certain lending partners. These lending partners retain ownership of the loans facilitated through Upstart’s platform forthree days or longer (the “holding period”) after origination, as required under the respective agreements. The Company has committed to purchase the loans at the conclusion of the required holding period. As of December 31, 2024 and 2025, the total loan purchase commitment included outstanding principal balance of $72.8 million and $116.9 million, respectively.
The Company has extended a line of credit in connection with one of its committed capital and other co-investment arrangements. As of December 31, 2024, the Company had unfunded commitments related to the line of credit of $7.6 million. As of December 31, 2025, the Company hadno unfunded commitments related to the line of credit.
The Company has commitments to fund future advances on HELOCs. As of December 31, 2024 and 2025, these commitments were $7.6 million and $18.0 million, respectively, however, since these commitments could expire without being drawn upon, the total commitment amounts do not necessarily represent future cash requirements.
Contingencies
Accounting for contingencies requires the Company to use judgment related to both the likelihood of a loss and the estimate of the amount or range of loss. The Company records a loss contingency when it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. The Company discloses material contingencies when it believes a loss is not probable but reasonably possible and may voluntarily provide information on additional contingencies.
From time to time the Company is subject to, and it is presently involved in, various litigation and legal proceedings arising from the ordinary course of business activities, the outcome of which the Company cannot reasonably determine. Other than the class actions and derivative actions described below, the Company does not believe that it is presently a party to any litigation of which the outcome would individually, or taken together, have a material adverse effect on our business, operating results, cash flows, or financial condition. As of December 31, 2024 and 2025, immaterial loss contingencies were recorded in connection with legal proceedings.
Indemnifications
In the ordinary course of business, the Company may provide indemnifications of varying scope and terms to vendors, directors, officers and other parties with respect to certain matters. In addition, the Company has entered into indemnification agreements with directors and certain officers and employees that will require the Company, among other things, to indemnify them against certain liabilities that may arise by reason of their status or service as directors, officers or employees. No demands have been made upon the Company to provide indemnification under such agreements, and thus, there are no claims that the Company is aware of that could have a material adverse effect on the Company’s consolidated financial statements.
Repurchases
Under the terms of our agreements with lending partners and institutional investors, as well as in agreements with investors in securitizations and pass-through certificate transactions, the Company may, in certain circumstances, become obligated to repurchase loans from or indemnify such lending partners and institutional investors. Generally, these circumstances include the occurrence of verifiable identity theft, the failure of sold loans to meet the terms of certain loan-level representations and warranties that speak as of the time of origination or sale, the failure to comply with other contractual terms with lending partners and institutional investors, or a violation of the applicable federal, state, or local lending laws.
The maximum potential amount of future payments associated with any repurchase or indemnification obligation is the outstanding balances of the loans held by lending partners and institutional investors, which as of December 31, 2024 and 2025, was $11,237.2 million and $14,290.4 million, respectively. Actual payments made relating to the Company’s repurchase and indemnification obligations were $6.0 million and immaterial for the year ended December 31, 2024 and 2025, respectively.
The Company did not have material contingent liabilities related to future loan repurchase obligations as of December 31, 2024 and 2025. These amounts are included in accrued expenses and other liabilities on the Company’s consolidated balance sheets.
Legal
On July 26, 2022, a lawsuit was filed in United States District Court, Southern District of Ohio, captioned Crain v. Upstart Holdings, Inc. et al., Case No. 2:22-cv-02935-ALM-EPD (S.D. Ohio) against the Company, the Company’s Chief Executive Officer, and Chief Financial Officer, alleging that the defendants made false and/or misleading statements or omissions about the Company’s business, operations, and prospects in violation of Section 10(b) of the Securities Exchange Act of 1934, as amended, or the Exchange Act, and Rule 10b-5 promulgated thereunder, as well as Section 20(a) of the Exchange Act. The Crain lawsuit claims unspecified damages and legal fees. On August 16, 2022, the court appointed a lead plaintiff and approved lead counsel in the Crain action. On December 5, 2022, the lead plaintiff filed a consolidated amended complaint, which names the same defendants as the previous complaint, along with two Company executives, as well as Third Point LLC and its CEO and Third Point Ventures LLC and its managing partner (also a former Upstart board member). The consolidated amended complaint brings the same claims as the previous complaint but adds a claim under Section 20A of the Exchange Act. On February 24, 2023, the defendants filed motions to dismiss the consolidated amended complaint. On September 29, 2023, the Court issued an order, granting in part and denying in part the Upstart defendants’ motion, and granting the motion filed by Third Point LLC and its CEO and Third Point Ventures LLC. On November 7, 2023, the Upstart defendants filed a motion for reconsideration, which the Court denied on August 5, 2024. On February 2, 2024, Lead Plaintiff, Universal-Investment-Gesellschaft mbH, and plaintiffs, Kathy Brooks and Kevin Crain, filed a motion for an order to certify this matter, now captioned In re Upstart Holdings Securities Litigation, as a class action, appoint themselves as class representatives, and approve their selection of Motley Rice LLC and Robbins Geller Rudman & Dowd LLP as co-class counsel, which motion the Court granted on March 27, 2025. On December 6, 2024, plaintiffs filed a motion for leave to file a first amended complaint, which motion the Court granted on September 29, 2025. The first amended complaint adds back as defendants Third Point LLC and its CEO and Third Point Ventures LLC. On November 14, 2025, Third Point LLC, its CEO, Third Point Ventures LLC, and its managing partner moved to dismiss the claims asserted against them in the first amended complaint, which motion plaintiffs opposed on January 8, 2026. The Company believes the remaining claims in the action are without merit and intends to defend itself vigorously.
On July 28, 2022, a derivative lawsuit was filed in United States District Court, Southern District of Ohio, captioned OConnor v. Huber et al., Case No. 2:22-cv-02961-EAS-KAJ (S.D. Ohio). The OConnor action includes allegations similar to those in the Crain complaint, and names as defendants each of the Company’s current board members and its Chief Financial Officer. The Company is named as a nominal defendant. The OConnor action includes claims for violation of Section 10(b) of the Exchange Act and Rule 10b-5 promulgated thereunder, breach of fiduciary duty, aiding and abetting breach of fiduciary duty, unjust enrichment, and waste of corporate assets. The OConnor action seeks unspecified monetary damages and an accounting from the individual defendants. The OConnor action also seeks unspecified corporate governance and internal procedure modifications, punitive damages, and legal fees.
On October 7, 2022, a second derivative lawsuit was filed in United States District Court, Southern District of Ohio, captioned Chung v. Huber et al., No. 2:22-cv-03620-MHW-CMV (S.D. Ohio). The Chung action includes allegations similar to those in the OConnor complaint, and names as defendants each of the Company’s current board members, a former board member, and its Chief Financial Officer. The Company is named as a nominal defendant. The Chung action includes claims for violation of Section 10(b), 14(a), and 21D of the Exchange Act, breach of fiduciary duties, unjust enrichment, abuse of control, gross mismanagement, and waste of corporate assets. The Chung action seeks unspecified monetary damages, restitution, and attorney’s fees and costs from the individual defendants. It also seeks corporate governance and internal procedure modifications.
On December 12, 2022, in response to a joint motion by the parties, the Court consolidated the OConnor and Chung matters, appointed co-lead counsel, and stayed the consolidated case until resolution of the related securities class action. On April 24, 2024, the plaintiffs in the consolidated action filed an amended complaint. The amended complaint includes allegations similar to those in the initial complaint in the OConnor action, and names the same defendants as the initial complaint, along with an additional Company executive and another former board member. The amended complaint brings the same claims as the initial complaint in the OConnor action but adds claims under Section 14(a) of the Exchange Act and Rule 14a-9 promulgated thereunder, for contribution under Sections 10(b) and 21D of the Exchange Act, and for abuse of control and gross mismanagement. The amended complaint seeks similar relief to that sought in the initial complaint in the OConnor action.
On February 3, 2023, a third derivative lawsuit was filed, in the United States District Court, District of Delaware, captioned Hsu v. Girouard, et al., 1:23-cv-00132-UNA (D. Del.). The Hsu action includes allegations similar to those in the consolidated derivative matter pending in Ohio, and names as defendants each of the Company’s current board members, a former board member, and its Chief Financial Officer. The Company is named as a nominal defendant. The Hsu action includes claims for violation of Section 14(a) of the Exchange Act as well as breach of fiduciary duties, and seeks unspecified monetary damages, restitution, and attorney’s fees and costs from the individual defendants. It also seeks corporate governance and internal procedure modifications. On February 16, 2023, in response to a joint stipulation and proposed order submitted by the parties, the Court stayed the Hsu action until resolution of the related securities class action.
On March 8, 2023, a fourth derivative lawsuit was filed, in the United States District Court, District of Delaware, captioned Sornchai et al. v. Girouard, et al., 1:23-cv-00253-MN (D. Del). The Sornchai action includes allegations similar to those in the consolidated derivative matter pending in Ohio, and names as defendants each of the Company’s current board members, a former board member, its Chief Financial Officer, and a Company executive. The Company is named as a nominal defendant. The Sornchai action includes claims for violations of Sections 10(b), 14(a) and 21D of the Exchange Act, breach of fiduciary duties, breach of fiduciary duty through misappropriation of material non-public information, and unjust enrichment, and seeks unspecified monetary damages, restitution, and attorney’s fees and costs from the individual defendants. It also seeks corporate governance and internal procedure modifications. On March 24, 2023, in response to a joint stipulation and proposed order submitted by the parties, the Court stayed the Sornchai action until resolution of the related securities class action.
On April 5, 2023, a fifth derivative lawsuit was filed, in the Court of Chancery of the State of Delaware, captioned Okhai v. Girouard, et al., C.A. No. 2023-0401-BWD (Del. Ch.). The Okhai action includes allegations similar to those in the consolidated derivative matter pending in Ohio, and names as defendants the Company’s current board members, two former board members, its Chief Financial Officer, and two current or former Company executives, as well as Third Point LLC and Third Point Ventures LLC. The Okhai action includes claims for breach of fiduciary, aiding and abetting such alleged breaches, and unjust enrichment, and seeks equitable and/or injunctive relief, restitution, and attorney’s fees and costs from the individual defendants. On August 3, 2023, in response to a motion to stay by the defendants in the Okhai action, the Court stayed the Okhai action until resolution of the motion to dismiss in the related securities class action. Following the issuance of the September 29, 2023 order on the motion to dismiss in the related securities class action, on November 16, 2023, in response to a joint stipulation and proposed order submitted by the parties, the Court stayed the Okhai action until resolution of the motion for reconsideration of the September 29, 2023 order on the motion to dismiss in the related securities class action. Following denial of the motion for reconsideration in the related securities class action, the parties in the Okhai action finished briefing and argued the defendants’ motion to continue the stay. On October 24, 2024, the Court continued the stay until February 1, 2025. On January 31, 2025, the parties submitted to the Court a proposed schedule for briefing Defendants’ motion to continue the stay. On April 11, 2025, in response to a joint stipulation and proposed order submitted by the parties, the Court ordered that the case remain stayed pending plaintiffs filing a consolidated amended complaint on or before May 7, 2025, after which Defendants filed a renewed motion to stay. Subsequent developments are discussed below.
On October 13, 2023, a sixth derivative lawsuit was filed, in the Court of Chancery of the State of Delaware, captioned Romanyshyn v. Girouard, et al., C.A. No. 2023-1029-BWD (Del. Ch.). The Romanyshyn action includes allegations similar to those in the consolidated derivative matter pending in Ohio, and names as defendants current and former directors and Company executives, as well as Third Point LLC and its CEO, and Third Point Ventures LLC. The Romanyshyn action includes claims for breach of fiduciary, and seeks unspecified monetary damages, restitution, and attorney’s fees and costs from the individual defendants. It also seeks corporate governance and internal procedure modifications. On November 3, 2023, in response to a joint stipulation and proposed order submitted by the parties, the Court stayed the Romanyshyn action pending the outcome of the motion to stay in the related Okhai derivative action. Subsequent developments are discussed below.
On October 24, 2023, a seventh derivative lawsuit was filed, in the Court of Chancery of the State of Delaware, captioned Agarwal v. Girouard, et al., C.A. No. 2023-1075-BWD (Del. Ch.). The Agarwal action includes allegations similar to those in the consolidated derivative matter pending in Ohio, and names as defendants current and former directors and Company executives, as well as Third Point LLC and its CEO, and Third Point Ventures LLC. The Agarwal action includes claims for breach of fiduciary, and seeks unspecified monetary damages, restitution, and attorney’s fees and costs from the individual defendants. It also seeks corporate governance and internal procedure modifications. On November 3, 2023, in response to a joint stipulation and proposed order submitted by the parties, the Court stayed the Agarwal action pending the outcome of the motion to stay in the related Okhai derivative action. Subsequent developments are discussed below.
On November 22, 2024, in response to a joint stipulation and proposed order submitted by the parties, the Court consolidated the Okhai, Romanyshyn, and Agarwal matters under the consolidated caption In re Upstart Holdings, Inc. Derivative Litigation, Consolidated C.A. No. 2023-0401-BWD and appointed co-lead plaintiffs and co-lead counsel. On May 7, 2025, the plaintiffs in the consolidated action filed a consolidated amended complaint. The consolidated amended complaint names as plaintiffs Evan Levitan and Charlie Romanyshyn and removes plaintiffs Okhai and Agarwal. The consolidated amended complaint includes allegations similar to those in the initial Okhai complaint and names the same defendants as the initial Okhai complaint, along with the CEO of Third Point LLC. The consolidated amended complaint brings the same claims as the initial Okhai complaint and seeks similar relief. On June 4, 2025, Defendants filed a renewed motion to stay, which motion the Court granted on August 25, 2025.
Given the uncertainty of litigation described above, the preliminary stage of the cases, and the legal standards that must be met for, among other things, class certification and success on the merits, the Company cannot estimate the reasonably possible loss or range of loss that may result from these actions.
- Income Taxes
Income (loss) before income taxes consisted entirely of income (loss) from domestic operations of $(240.0) million, $(128.4) million, and $54.3 million for the calendar years ended December 31, 2023, 2024 and 2025, respectively. Income tax expense included in the consolidated statements of operations and comprehensive income (loss) consisted of the following:
| Year Ended December 31, | |||
|---|---|---|---|
| 2023 | 2024 | 2025 | |
| Current: | |||
| Federal | $— | $— | $— |
| State | 107 | 185 | 728 |
| Total current tax expense | 107 | 185 | 728 |
| Deferred: | |||
| Federal | $— | $— | $— |
| State | — | — | — |
| Total deferred tax expense | — | — | — |
| Total provision for income taxes | $107 | $185 | $728 |
Income tax expense differed from the amount computed by applying the Federal statutory income tax rate of 21% to net income (loss) before income taxes for the years ended December 31, 2023, 2024 and 2025 as a result of the following:
| Year Ended December 31, | ||||||
|---|---|---|---|---|---|---|
| 2023 | 2024 | 2025 | ||||
| Amount | Rate | Amount | Rate | Amount | Rate | |
| U.S. federal statutory tax rate | $(50,405) | 21.00% | $(26,963) | 21.00% | $11,409 | 21.00% |
| State and local income taxes, net of federal income tax effect(1) | 28 | (0.01)% | 180 | (0.14)% | 672 | 1.24% |
| Foreign tax effects | — | —% | — | —% | — | —% |
| Effect of changes in tax law or rates enacted in the current period | — | —% | — | —% | — | —% |
| Effect of cross-border tax laws | — | —% | — | —% | — | —% |
| Tax credits | ||||||
| Research and development tax credits | (6,288) | 2.62% | (7,806) | 6.08% | (10,187) | (18.75)% |
| Changes in valuation allowance | 38,189 | (15.91)% | 50,585 | (39.40)% | 9,711 | 17.87% |
| Nontaxable or nondeductible items | ||||||
| Stock-based compensation | 2,306 | (0.96)% | (30,120) | 23.46% | (26,048) | (47.94)% |
| Section 162(m) limitation | 16,586 | (6.91)% | 13,840 | (10.78)% | 15,304 | 28.17% |
| Other | 490 | (0.20)% | 381 | (0.30)% | 544 | 1.00% |
| Changes in unrecognized tax benefits | 287 | (0.12)% | 178 | (0.14)% | 426 | 0.78% |
| Other adjustment | ||||||
| Federal provision-to-return adjustment | (1,154) | 0.48% | (608) | 0.47% | (1,133) | (2.09)% |
| Other | 68 | (0.03)% | 518 | (0.40)% | 30 | 0.06% |
| Effective tax rate | $107 | (0.04)% | $185 | (0.15)% | $728 | 1.34% |
(1)State taxes in Pennsylvania and Texas made up the majority (greater than 50 percent) of the tax effect in this category.
On July 4, 2025, the One Big Beautiful Bill Act (the “Act”) was enacted into law. The Act includes significant changes to the U.S. tax code, including restoration of immediate recognition of domestic research and development (“R&D”) expenditures and reinstatement of 100% bonus depreciation for qualifying property. The Company has assessed the Act’s impact and concluded that it did not materially affect its effective tax rate for the current quarter. The Company has elected to immediately expense domestic R&D expenditures incurred in 2025 and will continue to amortize any previously capitalized amounts over the original amortization period.
The tax effects of temporary differences that gave rise to significant portions of the Company’s deferred tax assets and liabilities related to the following:
| December 31, | ||
|---|---|---|
| 2024 | 2025 | |
| Deferred tax assets: | ||
| Net operating loss carryforwards | $346,356 | $357,440 |
| Research and development tax credits | 56,675 | 69,300 |
| Capitalized research and experimental expenditures | 84,572 | 65,211 |
| Accruals and reserves | 19,494 | 18,795 |
| Convertible debt transactions | 1,189 | 12,574 |
| Investment in partnerships | — | 11,363 |
| Stock-based compensation | 12,249 | 10,622 |
| Operating lease liabilities | 14,564 | 5,456 |
| Amortization | 612 | 322 |
| Other | 402 | 288 |
| Total deferred tax assets | 536,113 | 551,371 |
| Less: valuation allowance | (508,966) | (531,883) |
| Deferred tax assets – net of valuation allowance | 27,147 | 19,488 |
| Deferred tax liabilities: | ||
| Servicing rights | 7,607 | 9,436 |
| Right of use asset | 12,587 | 4,234 |
| Interest receivables | 2,481 | 2,821 |
| Intangible assets | 2,728 | 2,135 |
| Depreciation | 1,183 | 784 |
| Investment in partnerships | 242 | — |
| Other | 319 | 78 |
| Total deferred tax liabilities | 27,147 | 19,488 |
| Net deferred tax assets | $— | $— |
Management believes that, based on available evidence, both positive and negative, it is more likely than not that the deferred tax assets will not be utilized, and as such the Company maintains a full valuation allowance at December 31, 2025. The valuation allowance increased by $22.9 million for the year ended December 31, 2025 primarily as a result of current year activities.
As of December 31, 2025, the Company had approximately $1,164.9 million and $1,680.0 million of federal and state (post-apportioned) net operating losses (NOL), that will begin to expire in 2035 and 2034, respectively. The Company has Federal and California research and development tax credits of approximately $77.3 million and $28.1 million, respectively. The Federal research credits will begin to expire in 2032 and the California research credits have no expiration date. The Internal Revenue Code (“IRC”) limits the amount of NOL carryforwards that a company may use in a given year in the event of certain cumulative changes in ownership over a three-year period as described in Section 382 of the IRC. Utilization of NOL carryforwards and credits may be subject to a substantial annual limitation due to the ownership change limitations provided by the Internal Revenue Code of 1986, as amended, and similar state provisions. The annual limitation may result in the expiration of net operating losses and credits before utilization. The Company performed an ownership analysis and identified ownership changes in prior years, as defined under IRC Section 382 and 383, however neither resulted in a material limitation that will reduce the total amount of NOL carryforwards and credits that can be utilized.
A reconciliation of the beginning and ending balances of gross unrecognized tax benefits is as follows:
| Year Ended December 31, | |||
|---|---|---|---|
| 2023 | 2024 | 2025 | |
| Balance at beginning of year | $18,474 | $22,158 | $26,466 |
| Additions for tax positions of prior years | 308 | 179 | 441 |
| Tax positions related to the current year | 3,376 | 4,129 | 5,290 |
| Balance at end of year | $22,158 | $26,466 | $32,197 |
If recognized, all of the unrecognized tax benefits would not impact the effective tax rate due to the valuation allowance against certain deferred tax assets. As of December 31, 2025, the Company had $32.2 million unrecognized income tax benefits and there was increases of $5.7 million to the Company’s unrecognized tax benefits during the year. The Company’s policy is to classify interest and penalties associated with unrecognized tax benefits as income tax expense. The Company hadno interest or penalty accruals associated with uncertain tax benefits in its consolidated balance sheet and consolidated statement of operations and comprehensive income (loss) for the tax year ended December 31, 2025.
The Company files income tax returns in the U.S. Federal jurisdiction and various state and local jurisdictions. The Company is currently under examination by the Internal Revenue Service with respect to its U.S. federal income tax return for the 2023 tax year. The Company is not under examination by state or local income tax authorities at this time. However, because the Company has net operating losses and credits carried forward in several jurisdictions, certain items attributable to closed tax years are still subject to adjustment by applicable taxing authorities through an adjustment to tax attributes carried forward to open years. All tax returns will remain open for examination by the federal and most state taxing authorities for three years and four years, respectively, from the date of utilization of any net operating loss carryforwards or research and development credits.
The Company paid income taxes to multiple jurisdictions during the period. The table below summarizes income taxes paid, net of refunds received, to federal, state and local, and foreign tax authorities:
| Year Ended December 31, | |||
|---|---|---|---|
| 2023 | 2024 | 2025 | |
| Federal | $— | $— | $— |
| State and local | (658) | 258 | 590 |
| Foreign | — | — | — |
| Total | $(658) | $258 | $590 |
Income taxes paid (net of refunds) exceeds 5 percent of total income taxes paid (net of refund) in the following jurisdictions:
| Year Ended December 31, | |||
|---|---|---|---|
| 2023 | 2024 | 2025 | |
| State and local | |||
| California | $(1,200) | * | * |
| New York | 184 | 71 | 119 |
| North Carolina | 88 | 30 | 117 |
| Tennessee | * | 32 | 107 |
| Oregon | 67 | 36 | 94 |
| New York City | 92 | 22 | 58 |
| Texas | 52 | 45 | 46 |
| Louisiana | * | * | 30 |
- Jurisdiction below the threshold for the period presented.
- Net Income (Loss) Per Share
Basic net income (loss) per common share is based on the weighted-average common shares outstanding during the relevant year. Diluted net income (loss) per share is based on the weighted-average common shares outstanding during the relevant year, adjusted for the dilutive effect of share-based awards and convertible debt.
For years in which the Company reports net losses, basic and diluted net loss per share are the same because potentially dilutive common shares are not assumed to have been issued if their effect is anti-dilutive.
| Year Ended December 31, | |||
|---|---|---|---|
| 2023 | 2024 | 2025 | |
| Numerator: | |||
| Net income (loss) attributable to common stockholders, basic | $(240,132) | $(128,581) | $53,601 |
| Add: Dilutive effect of convertible senior notes, net(1) | — | — | (4,881) |
| Net income (loss) attributable to common stockholders, diluted | $(240,132) | $(128,581) | $48,720 |
| Denominator: | |||
| Weighted-average common shares outstanding used to calculate net income (loss) per share, basic | 83,765,896 | 89,450,038 | 96,030,558 |
| Stock options, RSUs, and ESPP | — | — | 7,516,007 |
| Convertible senior notes(2) | — | — | 3,946,170 |
| Weighted-average effect of dilutive securities | — | — | 11,462,177 |
| Weighted-average common shares outstanding used to calculate net income (loss) per share, diluted | 83,765,896 | 89,450,038 | 107,492,735 |
| Net income (loss) per share, basic | $(2.87) | $(1.44) | $0.56 |
| Net income (loss) per share, diluted | $(2.87) | $(1.44) | $0.45 |
(1)For the year ended December 31, 2025, diluted earnings per share and diluted net income attributable to common stockholders excludes gain on extinguishment of debt and interest expense, net of tax, associated with convertible senior note activity during the year, as evaluated under the if-converted method.
(2)For the year ended December 31, 2025, includes incremental dilutive shares from the 2026 and 2032 convertible senior notes.
The following securities were excluded from the computation of diluted net income (loss) per share for the years presented, due to their anti-dilutive effect:
| Year Ended December 31, | |||
|---|---|---|---|
| 2023 | 2024 | 2025 | |
| Options to purchase common stock | 12,617,254 | 10,709,898 | 1,421,770 |
| Unvested RSUs | 5,534,394 | 3,703,631 | 2,438,250 |
| Purchase rights committed under the ESPP | 184,447 | 163,228 | 68,965 |
| Convertible senior notes | 2,318,078 | 15,929,353 | 14,880,726 |
| Total | 20,654,173 | 30,506,110 | 18,809,711 |
- Segment Information
The Company’s organization and management structure is designed to support development of different lending product offerings, which are grouped into three operating segments - Personal Lending (unsecured personal loans and small dollar loans), Auto Lending (auto refinance, auto retail loans, and auto secured personal loans(1)), and Other (HELOCs and other). These operating segments are separately managed and evaluated by the Chief Operating Decision Maker (“CODM”), the Company’s Chief Executive Officer, who allocates resources and assesses performance at this level. The Company has determined that onlyone operating segment, Personal Lending, meets the definition of a reportable segment.
The Company generates all its revenue in the U.S. and a majority is earned in exchange for the use of the Company’s platform and for borrower referrals as well as for loan servicing activities provided to its lending partners and institutional investors. Refer to “Note 2. Revenue” for further information related to the Company's disaggregation of revenue from fees by type of service.
Contribution Profit is the primary measure of segment profit and loss reviewed by the CODM to assess business performance and strategy, prepare the Company’s annual operating budget and financial forecasts, and communicate with the Company’s Board of Directors concerning the Company’s financial performance. The significant segment expenses regularly reviewed by the CODM in evaluating Contribution Profit include borrower acquisition costs and borrower verification and servicing costs. To derive Contribution Profit, the Company subtracts the sum of borrower acquisition costs as well as borrower verification and servicing costs from revenue from fees, net.
The following table presents financial information, including Contribution Profit, for the Company’s Personal Lending segment:
| Year Ended December 31, | |||
|---|---|---|---|
| 2023 | 2024 | 2025 | |
| Personal Lending | |||
| Revenue from fees, net | $552,447 | $624,832 | $929,218 |
| Borrower acquisition costs(2) | (85,599) | (115,198) | (235,371) |
| Borrower verification and servicing costs(3) | (99,906) | (107,388) | (130,284) |
| Contribution Profit for Personal Lending | $366,942 | $402,246 | $563,563 |
(1)Beginning in the third quarter of 2025, the Company reclassified auto secured personal loans from Personal Lending to Auto Lending operating segment. Prior period segment information reflects the change, which was immaterial to the Company’s consolidated financial statements.
(2)Borrower acquisition costs consist of the Company’s sales and marketing expenses adjusted to exclude costs not directly attributable to attracting a new borrower, such as payroll-related expenses for the Company’s business development and marketing teams, as well as other operational, brand awareness and marketing activities. These costs do not include reorganization expenses.
(3)Borrower verification and servicing costs consist of payroll and other personnel-related expenses for personnel engaged in loan onboarding, verification and servicing, as well as servicing system costs. It excludes payroll and personnel-related expenses and stock-based compensation for certain members of the Company’s customer operations team whose work is not directly attributable to onboarding and servicing loans. These costs do not include reorganization expenses.
The following table presents a reconciliation of total Contribution Profit to Net income (loss) before income taxes:
| Year Ended December 31, | |||
|---|---|---|---|
| 2023 | 2024 | 2025 | |
| Contribution Profit: | |||
| Personal Lending | $366,942 | $402,246 | $563,563 |
| Reconciling items: | |||
| Other Contribution Profit/(Loss)(1) | (13,648) | (20,713) | (32,469) |
| Sales and marketing, net of borrower acquisition costs(2) | (36,626) | (41,783) | (45,270) |
| Customer operations, net of borrower verification and servicing costs(3) | (33,798) | (29,080) | (25,697) |
| Engineering and product development | (280,138) | (253,653) | (257,602) |
| General, administrative, and other | (212,388) | (230,935) | (253,740) |
| Interest income, interest expense, and fair value adjustments, net | (46,869) | 1,062 | 93,846 |
| Other income, net | 21,206 | 18,793 | 24,324 |
| Expense on convertible notes | (4,706) | (7,694) | (19,872) |
| Gain on debt extinguishment | — | 33,361 | 7,246 |
| Net income (loss) before income taxes | $(240,025) | $(128,396) | $54,329 |
(1)Includes Auto Lending and Other operating segments, which did not meet the separate reporting or aggregation criteria under GAAP.
(2)Borrower acquisition costs were $90.5 million, $125.0 million and $256.2 million for the years ended December 31, 2023, 2024 and 2025, respectively. Borrower acquisition costs consist of the Company’s sales and marketing expenses adjusted to exclude costs not directly attributable to attracting a new borrower, such as payroll-related expenses for the Company’s business development and marketing teams, as well as other operational, brand awareness and marketing activities. These costs do not include reorganization expenses.
(3)Borrower verification and servicing costs were $116.6 million, $128.9 million and $162.7 million for the years ended December 31, 2023, 2024 and 2025, respectively. Borrower verification and servicing costs consist of payroll and other personnel-related expenses for personnel engaged in loan onboarding, verification and servicing, as well as servicing system costs. It excludes payroll and personnel-related expenses and stock-based compensation for certain members of the Company’s customer operations team whose work is not directly attributable to onboarding and servicing loans. These costs do not include reorganization expenses.
The CODM does not evaluate operating segments using asset information and, accordingly, the Company does not report asset information by segment.
- Reorganization Expenses
On January 31, 2023, the Company implemented a plan of reorganization (the “January 2023 Plan”). The January 2023 Plan was designed to reduce operating costs, streamline operations and return the Company to profitability. As part of the January 2023 Plan, the Company reduced its workforce by approximately 20%, or 365 employees, and suspended development of its small business loan product.
During the year ended December 31, 2023, the Company incurred $15.5 million of reorganization expenses in relation to the January 2023 plan, which primarily consisted of severance charges related to employee cash compensation, benefits, and associated taxes. The Company also recognized an impairment expense of $2.6 million for previously capitalized internally developed software costs. In addition to these charges, the Company recognized $2.9 million of one-time non-cash savings related to the reversal of previously expensed stock-based compensation associated with forfeited stock awards for the year ended December 31, 2023. These reorganization costs are reported in the relevant operating expense category on the consolidated statements of operations and comprehensive loss.
To further decrease operating costs and streamline operations, the Company implemented an additional series of initiatives which reduced the Company’s workforce by approximately 13% during the year ended December 31, 2024. In relation to these initiatives, the Company incurred $4.4 million in charges related to severance payments, employee benefits and associated taxes. These reorganization costs are reported in the relevant operating expense category on theconsolidated statements of operations and comprehensive income (loss).
During the year ended December 31, 2025, the Company incurredno reorganization expenses.
- Subsequent Events
The Company has evaluated events that have occurred through the filing date of this Annual Report on Form 10-K. Based on its evaluation, other than any items recorded or disclosed within the consolidated financial statements and related notes, the Company has determined no subsequent events were required to be recognized or disclosed.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.